Elucidation of the Retinoid Signalling Pathway Involved in Axon Guidance in Lymnaea stagnalis and Xenopus laevis by Rand, Christopher
  
 
 
Elucidation of the Retinoid Signalling Pathway Involved in 
Axon Guidance in Lymnaea stagnalis and Xenopus laevis 
 
 
Christopher D. Rand, Hon. B.Sc. 
 
 
A thesis submitted to the Department of Biological Sciences 
in partial fulfillment of the requirements for the 
degree of Master of Science 
 
 
October, 2012 
Brock University 
St. Catharines, Ontario 
 
 
 
© Christopher D. Rand. 2012 
2 
 
Abstract 
The vitamin A metabolite, retinoic acid (RA), is known to play a crucial role in several 
developmental processes including axial patterning and differentiation. More recently, RA has 
been implicated in the regenerative process acting through its classical signaling pathway, the 
nuclear receptors, retinoic acid receptor (RAR) and retinoid X receptor (RXR), to mediate gene 
transcription. Moreover, RA has been shown to act as a guidance molecule for growth cones of 
regenerating motorneurons of the pond snail, Lymnaea stagnalis. Our lab has recently shown that 
RA can induce this morphological response independent of nuclear transcription, however, the 
role of the retinoid receptors in RA-induced chemoattraction is still unknown. Here, I show that 
the retinoid receptors, RXR and RAR, may mediate the growth cones response to the 
metabolically active retinoic acid isomers, all-trans and 9-cis RA, in Lymnaea stagnalis. Data 
presented here show that both an RXR and RAR antagonist can block growth cone turning in 
response to application of both isomers. Because no prior investigations have shown growth cone 
turning of individual vertebrate neurons, I aimed to show that both retinoic acid isomers were 
capable of inducing growth cone turning of embryonic spinal cord neurons in the frog, Xenopus 
laevis. For the first time in Xenopus, I showed that both all-trans and 9-cis RA were able to 
induce significantly more neurite outgrowth from cultured embryonic spinal cord neurons and 
induce positive growth cone turning of individual growth cones. In addition, I showed that the 
presence of the RXR antagonist, HX531, blocked 9-cis RA-induced growth cone turning and the 
RARβ antagonist, LE135, blocked all-trans RA-induced growth cone turning in this species. 
Evidence provided here shows for the first time, conservation of retinoic acid-induced growth 
cone turning in a vertebrate model system. In addition, these data show that the receptors 
involved in this morphological response may be the same in vertebrates and invertebrates.   
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1.01 – General Introduction 
  A regenerative process is often thought of as a recapitulation of the developmental 
process first utilized to make original connections within the developing embryo. Essentially, 
during neural development, neuronal somas extend neuritic processes, which are guided through 
the environment by structures called growth cones. The growth cone acts as a chemosensor that 
responds to varying gradients of guidance cues to ensure proper target selection. Many guidance 
cues have been identified, but the cellular pathways by which they mediate their effects have not 
been fully identified. One such guidance cue, which has been shown to attract and guide 
neuronal growth cones from the pond snail, Lymnaea stagnalis, is the vitamin A metabolite, 
retinoic acid (RA). Recent work in our lab has investigated the sub-cellular mechanisms involved 
in this chemoattractive response (Dmetrichuk et al. 2006, 2008; Farrar et al. 2009). However, 
due to the complexity of the cellular interactions of RA, there are a number of possible 
candidates. RA has been classically thought of as a nuclear transcription factor involved in many 
developmental processes including axial patterning, neuronal differentiation and cell 
proliferation, working through the nuclear receptors; retinoic acid receptor (RAR) and retinoid X 
receptor (RXR; Maden, 2007). However, recent evidence suggests a non-classical, non-genomic 
role for RA in axon guidance through its receptors (Carter et al. 2010; Farrar et al. 2009).  
There is growing evidence for RA acting as a neurotrophic factor and more recently as a 
guidance cue, which is not uncommon, as many other trophic molecules have been shown to act 
as guidance cues, primarily in vertebrate model systems. The majority of studies on RA have 
utilized a vertebrate model, in fact, evidence indicating the potential chemotropic abilities of RA 
was first shown in vertebrates (Maden et al. 1998a). Since then we have extended the studies by 
looking at the effects of RA on individual growth cones in the pond snail, Lymnaea stagnalis and 
the South-African clawed frog, Xenopus laevis as neurons of these species are capable of 
regeneration in vitro. 
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 Therefore, my first aim was to investigate the role of RXR and RAR in RA-mediated 
growth cone turning in the mollusc, Lymnaea stagnalis. I then investigated the conservation of 
RA’s neurotrophic and chemotropic roles in the South-African clawed frog, Xenopus laevis. By 
utilizing embryonic spinal cord neurons from the frog, I determined, for the first time, whether 
two RA isomers, all-trans and 9-cis, were able to induce neurite outgrowth from these cultured 
neurons. I then sought to determine whether these two isomers were able to induce turning in 
developing growth cones and assess the role of their receptors in mediating this response. 
1.02 Axon guidance and the growth cone 
Throughout neural development, axons are guided by many different diffusible factors 
released from both intermediate and final target sites (Ming et al., 1997). This process is critical 
during development for proper initial functional innervation, as well as during regeneration, 
because innervation of the appropriate target is also required for functional recovery. Currently, 
it is thought that the main protein families responsible for axonal guidance and repulsion during 
development and regeneration are ephrins, netrins, semaphorins and slits (Bashaw and Klein, 
2010). The latter three have been shown to be involved in commissural axon guidance to ensure 
proper contralateral and ipsilateral axonal innervation. These proteins are chemotropic factors 
that are expressed in a gradient in order to exert their specific effects by guiding  developing 
axons.  
Regenerating neurons extend processes called neurites and at the tip of every neurite is a 
structure known as the growth cone (Figure 1A). The growth cone is integral in deciphering the 
various guidance cues it encounters as it grows. Chemotropic molecules act on the growth cone 
to either steer the neurite towards (chemoattractant) or away from (chemorepellant) the source of 
these guidance molecules, whether it be intermediate tissues or terminal target sites. Prior to a 
growth cone response, internal changes must first occur to enable the structure to turn. Within 
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the growth cone, local protein synthesis acts upon the internal actin and microtubule cytoskeleton 
to provide the growth cone and neurite with their overall shape and dynamic movement (Dos 
Remidios et al. 2003). Movement is generated by persistent extension and/or retraction of finger-
like projections termed filopodia and the vale-like lamellipodia (Erskine and Herrera, 2007) 
(Figure 1B). Neurotrophins have been shown to be important regulators of cytoskeletal dynamics 
responsible for actions such as axonal guidance and may serve this role during neural 
development (Ming et al., 1997). Classically, neurotrophic factors are a group of proteins that are 
able to promote the survival and growth of neurons. Paves and Saarma (1997) showed that 
neurotrophin-3 (NT-3), brain-derived neurotrophic factor (BDNF) and nerve growth factor 
(NGF) were able to direct rat dorsal root ganglion (DRG) growth cone turning (Paves and 
Saarma, 1997). Many of the guidance cues that the growth cone interacts with lead to activation 
of calcium (Ca
2+
)-dependent intracellular pathways involving the RhoGTPase family, the most 
notable of which are Ras homolog (Rho), Ras-related C3 (Rac) and cell division control protein 
42 (Cdc42). Their distribution within growth cones result in attraction or repulsion of the growth 
cone to various chemotropic molecules (Henley and Poo, 2004).  
Recent evidence has shown a role for the Vitamin A metabolite, retinoic acid (RA), as both 
a trophic and tropic factor. Our lab has shown that RA is capable of inducing neurite outgrowth 
from newt spinal cord explants (Dmetrichuk et al. 2005) and cultured snail neurons (Dmetrichuk 
et al. 2006). Furthermore, RA has been shown to act as a guidance cue in the chick (Maden et al. 
1998a), newt (Dmetrichuk et al. 2005) and snail (Dmetrichuk et al. 2006; Dmetrichuk et al. 
2008; Farrar et al. 2009).  
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Figure 1. Structure of a regenerating neurite and growth cone. (A) Phase contrast image 
of a cultured PeA neuron from Lymnaea stagnalis. Scale bar = 15µm. (B) A diagram 
depicting the morphology of and structures comprising the growth cone, most notably the 
filopodia and lamellipodia. The P-domain and the C-domain represent the peripheral and 
central domains of the growth cone respectively (Erskine and Herrera, 2007).  
 
 
1.03 Retinoic Acid 
RA is a vital molecule known to play a role in neural differentiation and axial patterning in 
several different species. In addition, there is growing evidence that RA plays a crucial role in 
the regenerative process (Carter et al. 2010; Carter et al. 2011; Corcoran et al. 2000, 2002a; 
Dmetrichuk et al. 2005, 2006; Maden et al. 1998; Prince and Carlone, 2003). It is unknown 
whether RA signalling seen in developmental processes is the same, or similar, to that seen in 
regeneration. However, recent literature has shown that disruption of the RA pathway in 
regeneration capable animals disrupts their ability to regenerate (Dmetrichuk et al. 2005, Carter 
et al., 2011).  Many studies have shown that the mammalian CNS retains the capacity to 
regenerate, but only under specific conditions that provide a permissive environment for neurons 
to extend processes and form new connections (Chernoff and Stocum, 1995; Ferretti and 
Whalley, 2008; Silver and Miller, 2004). Interestingly, artificially up-regulating RA levels in 
animals incapable of regeneration can induce functional recovery in models of spinal cord injury 
(Agudo et al. 2010). In addition, retinoid defects have been shown in a model of motor neuron 
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disease (Corcoran et al. 2002b). Because of the involvement of RA in many developmental and 
regenerative processes in the nervous system, it is important to understand the mechanism by 
which it exerts its effects.  
i. Retinoic acid synthesis, metabolism and signaling 
RA is an endogenous metabolite of Vitamin A that is obtained from the dietary intake of plant 
carotenoids or animal retinal esters, which can be stored as retinyl esters until needed (Maden, 
2007). Vitamin A is metabolically converted to three organic compounds: retinol (alcohol), 
retinal (aldehyde) or retinoic acid (acid) (Marill et al., 2003). Vitamin A circulates within the 
blood as retinol which is able to bind to retinol-binding proteins (RBPs) until it is required by 
cells. It can then be shuttled into the cytoplasm of a cell via membrane bound proteins (Figure 2; 
Niederreither and Dollé, 2008). Once in the cytoplasm, retinol is free to bind cellular retinol 
binding proteins (CRBP), which can facilitate the oxidation of retinol to retinal via alcohol 
dehydrogenase (ADH) and to retinoic acid, irreversibly, by the enzyme retinal dehydrogenase 
(RALDH) (Figure 2; Maden and Hind, 2003; Niederreither and Dollé, 2008).   The two most 
biologically active and well-studied RA isomers are all-trans and 9-cis retinoic acid (Appendix: 
Figure 25). It is still unknown as to whether all-trans RA and 9-cis RA are metabolised through 
separate mechanisms or through an isomerization reaction from one to the other (Maden and 
Hind, 2003).  Classically, following RA synthesis, retinoic acid can freely bind cellular RA-
binding proteins (CRAPBs), which are able to shuttle the molecule into the nucleus for autocrine 
signalling or out of the cell for paracrine signalling (Figure 2). Once in the nucleus, RA can bind 
to two nuclear receptor classes, the RARs and the RXRs, which act as transcription factors for 
various genes. RARs have been shown to bind both all-trans and 9-cis retinoic acid and form 
heterodimers with RXR (Maden, 2007). In contrast, the RXRs were previously thought to bind 
exclusively to 9-cis retinoic acid in vertebrates. However, literature suggests this may not be the 
case and that all-trans RA may also bind to RXRs in vertebrates, albeit at lower affinity than 9-
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cis RA (Heyman et al. 1992; Ulven et al. 2001). In addition, Nowickyj et al. (2008) found that 
both all-trans and 9-cis RA isomers bind with equal affinity to RXR in the locust. The RXR can 
form either homodimers, or heterodimers with orphan receptors such as the peroxisome 
proliferator-activated receptor (PPAR), nerve growth factor-induced clone B (NGFIB) and the 
nuclear receptor related 1 (NURR-1), which is located in dopaminergic neurons (Mangelsdorf 
and Evans, 1995; Chambon, 1996; Corcoran et al., 2000). The complex formed between the 
ligand (RA) and receptor (RXR or RAR)  then bind to specific DNA sequences located in the 
promoter region of target genes called retinoic acid response elements (RAREs) and retinoid X 
response elements (RXREs) (Figure 2; Chambon, 1996; Marill et al., 2003). RA receptors are 
highly conserved between species including humans, rats, mice and the frog, Xenopus laevis, all 
of which have three RARs (α,β,γ) (Blumberg et al. 1992; Kastner et al., 1994; van der Wees et 
al. 1998) and three RXRs (α,β,γ) (Kliewer et al., 1994; Marklew et al. 1994). Interestingly, until 
recently it was thought that only the RXR was present in non-chordate species as no RAR 
homolog had been identified. However, our lab recently cloned the first non-chordate RAR 
(LymRAR) in the pond snail, Lymnaea stagnalis (Carter, 2011).  
In order to maintain homeostasis of RA levels, RA is degraded via the CYP26 family of 
enzymes into polar metabolites, which can be eliminated from the cell and subsequently from the 
body. A detailed pathway for RA signalling is shown in Figure 2. 
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Figure 2. Retinoic acid synthesis and signalling pathway. RBP4: retinol binding protein, 
STRA6: stimulated by retinoic acid gene 6, CRBP: cellular retinol binding protein, ADH: 
alcohol dehydrogenase, RDH: retinol dehydrogenase, RALDH: retinal dehydrogenase, CRABP: 
cellular RA-binding protein, CYP26: cytochrome P450, family 26, RARE: retinoic acid response 
element. (Adapted from Niederreither and Dollé, 2008). 
 
1.04 Retinoic acid in development and regeneration 
RA is a vital biological molecule implicated in several crucial developmental processes 
including axial patterning, neural differentiation and configuration (Maden and Hind, 2003; 
Maden 2007). Endogenous RA synthesizing enzymes have been identified in several species at 
various developmental stages. RALDHs can be detected in the mouse embryo as early as day 7.5 
and are expressed following gastrulation (stage 4-5) in the developing chick (Ang and Duester, 
1997; Maden et al., 1998b). Retinol dehydrogenase (RDH) is localized to the developing CNS, 
ear and eye as well as the cranial and spinal ganglia, gut and myotomes in the mouse embryo 
(Romert et al., 1998). RA is found in the mouse node and chick Hensen’s node (Hogan et. al., 
1992; Chen and Solursh, 1992) as well as the Xenopus blastopore during gastrulation (Chen et. 
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al., 1994). This evidence shows that RA is indeed synthesized within the embryo and indicates 
its prevalence throughout development. Furthermore, endogenous RA can be detected in the 
chick and mouse embryo at varying levels along the neural tube. The forebrain and midbrain 
contain nearly undetectable levels whereas the region destined to form the spinal cord contains 
the greatest levels; the hindbrain on the other hand has transitional levels potentially due to 
diffusion of RA anteriorly, and/or RA degradation by Cyp26 (Maden, 2000). More recently, our 
lab has shown the presence of the RA receptors, RXR and RAR, in the developing Lymnaea 
embryo and the two biologically active RA isomers in the adult CNS (Carter et al. 2010; Carter, 
2011; Dmetrichuk et al. 2008). Taken together, these data show the presence and metabolism of 
RA in the embryo required for maintaining normal development. 
Due to the widespread production of RA, deficiencies in dietary vitamin A and disruptions 
in the pathway can cause severe abnormalities. Dickman et al. (1997) withdrew vitamin A from 
the diet of pregnant rats and noted malformation of the face, neural crest, eyes, heart, and 
nervous system of the developing fetus. Furthermore, White et al. (1998) showed a loss of 
posterior cranial nerves and existence of ectopic otic vesicles in vitamin A deficient (VAD) rats. 
Investigation into the effects of RAR double mutants revealed that RARαγ null mutants showed 
severe scoliosis, median facial cleft, axial and limb skeletal malformations, multiple eye 
abnormalities and glandular abnormalities (ocular and salivary) (Lohnes et al., 1994). Moreover, 
van der Wees et al. (1998) expressed a dominant-negative RARβ in Xenopus embryos which 
induced specific hindbrain abnormalities reminiscent of VAD quails that also showed neural tube 
defects (Maden et al., 1996). Furthermore, inhibition of RA synthesis by ethanol application 
induced severe craniofacial defects associated with fetal alcohol syndrome in the mouse (Deltour 
et al. 1996). Taken together, these examples illustrate the crucial role that RA plays in 
development, and any interference with the signalling pathway, whether through changes in 
synthesizing enzymes or the retinoid receptors, results in severe embryological abnormalities.  
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 RA is also implicated in tissue regeneration, which is not unexpected as the processes 
involved in regeneration of limbs, spinal cord, gut, etc. are ones thought to be involved in 
embryonic development. Therefore, regeneration can be thought of as a recapitulation of many 
developmental processes. In addition to the role of RA in development, extensive literature has 
provided evidence for its role as a trophic factor, more specifically a neurotrophin. Because 
neurotrophic factors promote the survival and growth of neurons, they are important following 
injury to minimize damage and to maintain function within the nervous system. It has been 
suggested that the absence of neurotrophins, (along with inhibiting factors such as glial scars and 
astrocytic debris), influence the survivability of neurons following physical damage and 
ultimately lead to cell apoptosis (Chernoff and Stocum, 1995; Ferretti and Whalley, 2008; Silver 
and Miller, 2004). A number of proteins and molecules have been regarded as neurotrophic 
factors; the first to be identified, NGF, was isolated and characterized by Cohen and Levi-
Montalcini (1956). Since then several other factors have been identified including: BDNF, NT-3 
and NT-4/5 in addition to glial cell‐line derived neurotrophic factor (GDNF), ciliary 
neurotrophic factor (CNTF), hepatocyte growth factor/scatter factor (HGF/SF) and several 
members of the fibroblast growth factor (FGF) family (Tonge and Leclere, 2000). Recently, RA 
has garnered greater interest as a potential neurotrophic agent as many of these properties seen 
with other trophic factors have been shown with RA.   
RA synthesis and signalling have been shown to be up-regulated following injury in several 
species. For example, Zhelyaznik et al. (2003) showed an increase in transcriptional activity of 
RALDH-2 and cellular retinol-binding protein-1 (CRBP-1) following peripheral nerve crush 
injury. Furthermore, a focal increase in RALDH-2 activity was seen following spinal cord 
contusions in rats (Mey et al. 2005). This evidence supports the role for RA as a neurotrophin, in 
that its metabolic up-regulation may serve as a neuroprotectant to shield healthy tissue from 
damage in the CNS and PNS following injury. Furthermore, inhibition of the RA signalling 
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pathway resulted in inhibition of tail and spinal cord regeneration in the newt (Carter et al., 
2011). Moreover, Corcoran et al. (2002b) showed that depriving retinoids from the diet caused 
motorneurons in adult rats to undergo neurodegeneration and that a defect in RARα is found in 
cases of spontaneous amyotrophic lateral sclerosis (ALS) in rats.  In addition, endogenous levels 
of 9-cis RA were found in the limb wound epidermis of regenerating urodeles and limb 
blastemas of fiddler crabs (Viviano et al. 1995; Hopkins, 2001). The evidence presented here 
points to a role for RA in not only limb and spinal cord regeneration, but suggests that defects in 
signalling may occur in instances of severe neurodegenerative diseases.  
Recently, our lab showed that in the CNS of adult Lymnaea, both all-trans (atRA) and 9-cis 
RA were present, and found at nearly equal concentrations (Dmetrichuk et al. 2008). 
Furthermore, both of these isomers have been shown to induce significant neurite outgrowth of 
cultured Lymnaea neurons (Dmetrichuk et al. 2006, 2008) and newt spinal cord explants 
(Dmetrichuk et al. 2005; Prince and Carlone, 2003; Rand, 2009; Zeglinski, 2008). In addition, 
several studies have shown atRA induced neurite extension of rat dorsal root ganglion (DRG; 
Corcoran et al. 2000) and embryonic chick neural tissue (Maden et al. 1998a). Therefore a 
physiological role for both these isomers in neural regeneration has been proposed, although the 
role of 9-cis RA in vertebrate regeneration has been less studied. Taken together, these data 
suggest a role for RA, not only as a neuroprotectant, but also as a trophic factor, where it has the 
capacity to induce regeneration of vertebrate and invertebrate neural tissue.  
  
1.05  Retinoic acid as a chemotropic molecule  
Recently, it has become apparent that RA can act not only as a neurotrophic factor, but also 
as a tropic factor, where it can guide neuritic processes from regenerating neural tissue. Although 
indirect, evidence for a chemotropic role for RA was shown in Vitamin A deficient (VAD) quail 
embryos, where axonal trajectories were found to be disorganized (and extensions reduced) in 
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the developing neural tube (Maden et al. 1996). Furthermore, when a gradient of atRA was 
applied to dorsal neural tube neurons from the chick, neurites which initially grew evenly (i.e. 
from all sides) from the soma, encountered this gradient of RA and showed a turning behaviour 
along the RA gradient (Maden et al. 1998a). In contrast, cells that were exposed to atRA in a 
non-gradient manner did not show a preferential growth trajectory and therefore grew in a 
dispersed manner. More direct evidence for RA chemoattraction was shown by Dmetrichuk et al. 
(2005) who demonstrated that atRA-soaked beads, which slowly released RA as a localized 
source, induced directed neurite extensions from adult newt spinal cord explants. Preliminary 
evidence has shown the same effect with 9-cis RA (Rand, 2009; Zeglinski, 2008).  In addition, 
co-culture of newt spinal cord explants with a newt limb blastema induced significant neurite 
outgrowth on the side of the explant in which the blastema was located (Prince and Carlone, 
2003). Interestingly, blocking the RARβ with an antagonist in these co-cultures abolished 
directed outgrowth. These data suggest that RA may act through the RARβ to influence axon 
trajectory and target selection in the newt (Dmetrichuk et al., 2005).   
Although evidence had suggested that RA can direct outgrowth from tissue explants, it 
had not been shown with individual growth cones. Accordingly, pulsatile micropipette 
application of atRA to cultured Lymnaea stagnalis motorneurons induced positive growth cone 
turning toward RA, indicating that RA is able to guide individual growth cones and act as a 
chemotropic molecule (Dmetrichuk et al. 2006). More recently, this same phenomenon has been 
shown with 9-cis RA (Dmetrichuk et al. 2008; Farrar et al. 2009). Classically, RA has been 
known to work through its nuclear receptors, RAR and RXR, to regulate gene transcription, 
however, recent evidence has indicated that a novel, non-genomic retinoid pathway may be 
mediating the growth cone turning response to RA, seen in Lymnaea stagnalis cultured neurons 
(Farrar et al. 2009).  
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1.06 Lymnaea stagnalis as a model for the study of RA in regeneration 
The pond snail, Lymnaea stagnalis, has been utilized in our lab as a model system for 
studying regeneration and the morphological, molecular and electrophysiological actions of RA 
(Figure 3A). Unlike vertebrate models, the snail CNS allows us to culture single, identified 
neurons that have well characterized morphology and function in the CNS (Figure 3B). This 
procedure ensures that the same cell type is used consistently. In addition, neurons are isolated 
from adult animals and these cells retain the capacity to regenerate in culture making them great 
candidates with which to perform various morphological and electrophysiological experiments. 
In contrast, many vertebrate studies utilize embryonic tissues/cells or PNS neurons/ganglia that 
retain the ability to regenerate, though, they do not provide the ability to work with single, 
identifiable adult CNS cells. Furthermore, developmental and regenerational studies can be 
undertaken in the whole animal (in vivo), semi-intact preparation, as well as isolated cell cultures 
(in vitro). In fact, it has been shown that transplantation of single neurons into the brain of intact 
Lymnaea exhibit neurite outgrowth and can restore functional circuitry (Syed et al. 1992). Our 
lab has shown that by culturing identified cells such as Visceral F (VF) and Pedal A (PeA) 
neurons, bath application of RA (atRA and 9-cis RA) is able to induce a regenerative response 
by promoting and enhancing neurite outgrowth in the absence of any other neurotrophins 
(compared to Ethanol treated controls) (Dmetrichuk et al. 2006; Dmetrichuk et al. 2008). 
Furthermore, in the isolated CNS preparation, an identified cell demonstrated enhanced neurite 
extensions in the presence of RA, following a nerve crush injury, which may have been a 
decrease in degeneration (i.e. neuroprotection) at the site of injury (Vesprini, 2011). In addition 
to its neurotrophic role, RA has been shown to have a chemotropic role in Lymnaea where focal 
application of RA (atRA and 9-cis RA) to an actively growing neurite elicited a positive growth 
cone turning response towards the source of RA (Dmetrichuk et al. 2006; Dmetrichuk et al. 
2008; Farrar et al. 2009). Furthermore, both RA isomers, atRA and 9-cis RA, were found to be 
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present in the CNS and haemolymph of Lymnaea indicating that RA likely plays a physiological 
role in this animal (Dmetrichuk et al. 2008).  
 
Figure 3. Lymnaea stagnalis and the isolated CNS. (A) The mollusc, Lymnaea 
stagnalis (Oxford Scientific, 2012; scale bar = 3mm). (B) The dissected central ring 
ganglia of Lymnaea stagnalis. LPeG and RPeG: left and right pedal ganglia. Scale bar = 
0.25mm (Courtesy of N. Vesprini). 
 
Since RA has been thought to act through its nuclear receptors via the classical pathway, 
work has been extended to assess the role of nuclear transcription in RA-mediated growth cone 
turning. First, Farrar et al. (2009) showed that bath application of Actinomycin D, an inhibitor of 
nuclear transcription, did not block RA-mediated growth cone turning, suggesting a possible 
non-genomic role for RA (contrary to the classical nuclear retinoid pathway). Second, these 
investigators performed the same growth cone experiments with transected neurites to ensure 
that the regenerating neurites and growth cones were physically isolated from the soma and 
therefore prevented any nuclear transcripts from being shuttled to the growth cone over the 
course of the assay. Interestingly, RA-mediated growth cone turning persisted in the isolated 
neurites, again suggesting that RA may be working through a non-genomic signaling pathway. 
Third, in order to determine the necessity of local protein synthesis, anisomycin was applied and 
RA-induced growth cone turning of isolated neurites was inhibited, suggesting that de novo 
protein synthesis is required to allow growth cone turning in response to RA.   
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Carter et al. (2010) recently cloned and characterized a LymRXR showing presence of the 
protein with Western blotting in whole snail CNS tissue. Despite being traditionally known as a 
nuclear receptor, the RXR protein was found in the cytoplasm, neurite and growth cones of 
cultured neurons using immunohistochemistry. Due to this non-nuclear distribution in neurons, 
our lab studied a potential non-genomic role of the RXR in the RA-mediated growth cone 
turning response. Carter et al. (2010) found that focal application of the RXR pan-agonist PA024 
to isolated neurites induced positive growth cone turning toward the source of the agonist, 
suggesting that local RXR may mediate this response. Furthermore, bath application of either of 
the RXR pan-antagonists, PA452 or HX531, inhibited the RXR agonist-induced growth cone 
turning, suggesting that the actions of the RXR pan-agonist were selectively at the RXR.  
It was previously believed that invertebrate species did not possess RARs, however, 
genomic screening predicted the presence of an ancestral RAR gene in the annelid, Capitella 
capitata, and in the mollusc, Lottia gigantea. Based on this evidence, a novel, non-chordate RAR 
was identified and cloned in the pond snail Lymnaea stagnalis (Carter, 2011). Similar to the 
LymRXR, the LymRAR was present in CNS tissue samples as well as in cultured neurons. 
Furthermore, the RAR was shown to have a non-nuclear localization in cultured cells whereby 
staining revealed its presence in the cytoplasm, neurite and growth cones of PeA neurons, a 
pattern similar to that seen with RXR staining (Carter, 2011). These previous studies, did not 
however, determine whether this neurite-localized RAR played any role in RA-mediated growth 
cone turning. 
1.07 Xenopus laevis as a model 
The South-African clawed frog, Xenopus laevis, has long been used as a model for the study 
of developmental processes, as their life stages are well characterized. Many molecular, 
morphological and electrophysiological techniques have been used with great success in 
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determining the roles of various molecules and proteins within the adult and embryonic frog 
nervous system. Furthermore, many investigators have used this model to study regeneration, as 
the Xenopus tadpole retains the ability to regenerate its limbs and tail. One of the main 
advantages of using this animal is that their eggs are relatively easy to obtain. Gravid females 
release hundreds of eggs following hormonal injection (or natural processes) and these eggs are 
robust and easily fertilizable with a high success rate.  As stated earlier, staging is well 
established by Nieuwkoop and Faber (1956) ensuring the experimenter is consistently collecting 
cells from the proper developmental stage. In our experiments, the stage 22 embryo is used for 
culturing spinal cord neurons, as this is the stage in which the neural tube is fully formed and a 
distinct anterior/posterior axis is apparent (Figure 4B). In addition, we are able to assess the 
effects of a particular molecule, in this case retinoic acid, on a single cultured cell as opposed to 
other vertebrates such as newts where it is much more difficult. Furthermore, frog embryonic 
cells are much larger than many other vertebrate cells and these cells have been used extensively 
for looking at outgrowth and growth cone turning with various guidance cues with great success 
(Henley and Poo, 2004; Ming et al. 1997, 2001; Song et al. 1997; Song et al 1998; Song and 
Poo, 1999; Zheng et al. 1994). However, unlike the invertebrate model, Lymnaea stagnalis, the 
frog cell cultures consist of a heterogeneous mixture of various cell types, including different 
neuronal and non-neuronal subtypes. Without using specific cell markers, cells in this case, are 
identified strictly based on morphology. The neurotrophic and chemotropic effects of retinoic 
acid on cultured spinal cord neurons have not yet been tested in this amphibian model. Although 
RA is known to exert neurotrophic effects in vertebrates, its effects in Xenopus have not yet been 
studied. Furthermore, no studies have yet demonstrated that RA can induce single growth cone 
turning of vertebrate neurons. 
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Figure 4. The adult and developing South African clawed frog. (A) The South-African 
clawed frog, Xenopus laevis (van der Voort, 2012, scale bar = 3cm). (B) The developing 
embryo of Xenopus laevis.  A and P: anterior and posterior ends of the embryo, NT: neural tube. 
The box depicts the area dissected and used for spinal cord cultures. Scale bar = 0.5mm. 
 
 There have been several molecules identified as neurotrophins, originally in an 
invertebrate model, as potential regeneration-inducing molecules in vitro. Many of these 
molecules were then shown to act as guidance cues in various vertebrate models, including 
Xenopus. The most notable of these are BDNF, Netrin 1, NT-3 and NGF. In addition, other 
guidance cues have been shown to act on Xenopus growth cones including semaphorin-III (Sema 
III), myelin associated glycoprotein (MAG) and the neurotransmitter Acetylcholine (ACh). It 
was shown that Xenopus spinal cord neurons were attracted to an applied gradient of the 
neurotransmitter ACh, along with BDNF, Netrin-1, NT-3 and NGF (Zheng et al. 1994; Song et 
al. 1997, Ming et al. 1997, 2001; Song and Poo, 1999). Conversely, molecules such as Sema-III 
and MAG act as chemorepulsive agents in Xenopus (Song et al 1998; Henley and Poo, 2004).  
 Although the effects these agents have on growth cone guidance is well-established, the 
pathways they activate were previously unclear. It was shown however, that these guidance cues 
activated second messenger systems within the neuron and growth cone that ultimately lead to 
activation or inhibition of the cAMP or cGMP pathways (Song and Poo, 1999).  This group 
showed that the direction of guidance elicited by these cues was dependent on the levels of 
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cAMP or cGMP within the neurons and growth cone. More specifically, when the cAMP or 
cGMP pathways were inhibited through their primary mediators, protein kinase A (PKA) or 
protein kinase G (PKG), the previously chemoattractant guidance cues became chemorepulsive. 
Interestingly, this process also applied to chemorepulsive guidance cues where activation of 
these pathways caused chemorepulsive agents to become chemoattractant. Overall, these results 
suggested that some guidance cues mediate their effects through one of two second messenger 
systems, either cAMP or cGMP. From this, it was concluded that high levels of either cAMP or 
cGMP resulted in attraction. Conversely, low levels of each lead to repulsion (Song et al. 1998)).  
It has been known for decades that Ca
2+
 plays a crucial role in regulating growth cone 
motility due to its interactions with the cytoskeletal elements within the growth cone.  Previous 
research has shown that Xenopus spinal neurons cultured in low Ca
2+
 saline were no longer 
attracted to the chemoattractant guidance cues such as BDNF and or NGF (Song and Poo, 1999). 
In addition, large increases in cytosolic Ca
2+
 concentrations have been correlated with growth 
cone collapse (Bandtlow et al. 1993; Gomez et al. 1995). In contrast, it has been reported that an 
increase in [Ca
2+
]i in the growth cone of cultured Xenopus spinal neurons correlates with an 
attractive response to a guidance cue (Henley and Poo, 2004). These data suggest that there is an 
optimum level of Ca
2+
 within the cell and that alterations on either side of this window may 
induce negative effects. Interestingly, recent evidence from our lab has suggested that acute 
exposure to high levels of RA elicits a decrease in [Ca
2+
]i in the soma of cultured Lymnaea 
Visceral F (VF) neurons, suggesting that the soma may respond differently to neurotrophic and 
chemotropic agents than do the neurites and growth cones (Vesprini, 2011). However, it is more 
likely that the differences seen at the growth cone and the soma may be due to the difference in 
concentrations used in these experiments (higher levels used for soma experiments). 
Furthermore, previous work by Farrar et al. (2009) showed that the calcium channel blocker, 
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cadmium, blocked RA-mediated growth cone turning, suggesting Ca
2+
 influx is required for this 
response.  
The role of RA in Xenopus growth cone guidance and neurite outgrowth has not yet been 
investigated, however the teratogenic effects of RA during development have been well 
characterized in this species. As with many other animal models, excess levels of RA during 
embryogenesis lead to posteriorization of the frog embryo, often resulting in loss of anterior 
neural tissue and in some cases, embryos lacking heads (Altaba and Jessel, 1991). In addition, 
RA has been detected at various levels of development, most notably during gastrulation as 
previously stated. RA is not only present in the embryo but the RAR (α, β, γ) and RXR (α, β, γ) 
receptors it binds to have been cloned in Xenopus, allowing for manipulation of these receptors 
within the embryo (Sharpe, 1992; Crawford et al. 1995; Dollé, 2009). For example, van der 
Wees et al. (1998) expressed a dominant-negative RARβ in Xenopus embryos, which induced 
specific hindbrain abnormalities reminiscent of VAD quails (that also showed neural tube 
defects) (Maden et al., 1996).  
Although the role of RA in growth cone guidance in the frog, Xenopus laevis has not yet 
been investigated, RA has been shown to be important in several amphibian models with regards 
to regeneration. Previous evidence showed that RA was capable of inducing neurite outgrowth in 
isolated axolotl spinal cords (Hunter et al. 1991) and increased mean neurite length and number 
in the isolated newt spinal cord (Prince and Carlone, 2003; Dmetrichuk et al., 2005). Inhibition 
of retinal dehydrogenase mediated synthesis of RA by disulphiram caused lack of regeneration in 
the axolotl limb and tail (Maden, 1997). In addition, co-application of atRA and a RARβ 
antagonist (LE135) to isolated newt spinal cord caused a significant decrease in neurite 
outgrowth suggesting RA-induced outgrowth is mediated by a member of the RARβ family 
(Dmetrichuk et al., 2005). Furthermore, a significant reduction in neurite outgrowth (~61%) was 
also seen when explants were co-cultured with primary blastemas in the presence of LE135. This 
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suggests that atRA is a diffusible factor released from the blastema acting as a neurotrophic 
factor on cultured spinal cord explants. These features, along with growing evidence for the 
conservation of RA signalling in development and regeneration in vertebrates, makes Xenopus 
laevis an excellent model in which to conduct growth cone experiments on embryonic spinal 
cord neurons.  
1.08 Objectives 
The general objective of this thesis was to elucidate the role of RXR and the recently 
cloned RAR in RA-mediated growth cone turning in the pond snail, Lymnaea stagnalis. Based 
on prior investigations with an RXR agonist, I hypothesized that RXR mediates the growth cone 
turning response to RA. However, the role of the novel, non-chordate RAR is still unknown in 
this species as work with RAR agonists and antagonists have yielded mixed results for both 
development and electrophysiological effects of RA. Therefore this thesis aimed to determine if 
there is a role for this novel receptor in RA-mediated growth cone guidance.  
Previous literature has indicated that RA has a neurotrophic role in vertebrates, inducing 
significant neurite outgrowth in several species, (although not shown in Xenopus) (Corcoran et 
al. 2002; Dmetrichuk et al 2005; Maden, 1998a; Prince and Carlone, 2003). Furthermore, 
evidence has indicated RA may be able to guide vertebrate neurite outgrowth, but has yet to 
demonstrate that RA is able to cause turning of individual growth cones, as seen in invertebrate 
neurons. I thus aimed to show that the two biologically relevant RA isomers, all-trans and 9-cis, 
are capable of inducing both a neurotrophic (neurite outgrowth) and chemotropic (growth cone 
guidance) effect on embryonic spinal cord neurons in the frog, Xenopus laevis.  
My overall findings support a role for both RXR and the novel non-chordate RAR in RA-
mediated chemoattraction in Lymnaea neurons. Furthermore, I show a neurotrophic and 
chemotropic role for RA in Xenopus embryonic spinal cord neurons.  
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2.01 Animals: 
All vertebrate animals were cared for according to the guidelines of the Canadian Council 
on Animal Care (CCAC) and Brock University Animal Aare and Use committee 
The pond snail, Lymnaea stagnalis, was reared and housed in tanks containing artificial, 
aerated pond water (Instant Ocean Sea Salt, 5g/L) and was fed daily with romaine lettuce and 
fish food (Nutrafin Max Spirulina Algae Flake Food).  All animals used for cell culture work 
ranged in size from 12 to 15mm.  
The South-African clawed frogs, Xenopus laevis, were purchased from Boreal Labs (St. 
Catharines, ON) and housed in plastic tanks containing chlorine-free water. Females were fed 3-
4 pieces of beef liver per day in the week prior to obtaining oocytes, in order to enhance oocyte 
production. Otherwise, both males and females were fed Xenopus pellet food 2-3 times a week. 
 
2.02 Cell-culture procedures: 
Lymnaea: 
Snails were anaesthetized (25% Listerine in saline) and their central nervous systems 
(CNSs) were dissected out and given three, five minute antibiotic saline washes (ABS; 
Gentamicin (225µg/mL) Sigma-Aldrich). The CNSs were treated with trypsin (6mg in 3mL DM 
(Defined media (Sigma-Aldrich) ranging from 19-20.5 minutes, followed by trypsin inhibitor 
(6mg in 3mL DM, Sigma-Aldrich) for 10 minutes.  Defined media (DM) consists of 50% L-15 
(Leibowitz) media, Gentamicin (25ug/mL), 4X salts (NaCl 40mM, KCl 1.7mM, CaCl 4.1mM, 
MgCl 1.5mM and HEPES 10mM) , Glutamine (60mg/L), D-Glucose (54.05mg/L) and MilliQ 
water (~24.6%) with a pH of 7.9. The CNS was then pinned out in high osmolarity DM (800µL 
of 1M Glucose in 30mL DM) followed by removal of the connective tissue sheath covering the 
Pedal ganglia.  
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Individual identified motor neurons from the pedal ganglia called Pedal A neurons (PeA; 
Figure 4) were removed using a fire-polished glass pipette coated with Sigmacote to prevent cell 
adhesion (approximately 50-60µM in diameter; Sigma-Aldrich). A small amount of suction was 
applied using a microsyringe to remove individual cell bodies from the CNS. Cells were then 
placed into poly-L-lysine coated petri dishes (for full procedure refer to Farrar, 2009) containing 
2.5mL of conditioned media (CM, see below for details) and 0.5mL of DM. In order to promote 
neurite outgrowth, all-trans retinoic acid was also added (10
-7
M final concentration) to the 
culture dishes at the time of cell plating. 
 
Xenopus: 
Female frogs were injected with 600 units of Human Chorionic Gonadotropin (Sigma-
Aldrich), and then given a 200 unit booster injection the following morning if eggs were not 
seen. The females were milked to obtain eggs by gently squeezing their abdomen and oocytes 
were kept in 10% amphibian Ringer’s solution (100% Ringer’s: 115mM NaCl, 2.6mM KCl, 
2mM CaCl2, 10mM HEPES; diluted to 10% using MilliQ water, pH = 7.6). Males were 
sacrificed by decapitation and after pithing, their testes were removed. Testes were gently 
disrupted by homogenization and the sperm homogenate was added to the dish of oocytes. 
Following fertilization, indicated by the dark animal pole rotating upwards in the vitelline 
envelope in the majority of eggs, residual sperm were removed by washing with 10% Ringer’s 
solution and the zygotes were stored in fresh 10% Ringer’s solution at room temperature (RT). 
All fertilized oocytes were left overnight at RT to develop. Any unfertilized eggs were removed 
to prevent lysis and contamination of the healthy embryos.   
Approximately 24 hours post fertilization, the embryos had reached stage 22 of 
development (Nieuwkoop and Faber, 1956) characterized by complete formation of the neural 
tube (Figure 4). The jelly coats and vitelline envelopes were removed with watchmakers forceps 
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and the fertilized eggs washed in a series of six, five minute washes in 10% Ringer’s solution. 
After the last wash, embryos were transferred to calcium-magnesium free Ringer’s solution 
(CMF-Ringer’s; NaCl 115mM, KCl 2.6mM, HEPES 10mM and Ethylenediaminetetraacetic acid 
[EDTA] 0.4mM; pH = 7.6). The neural tube was then dissected away from the embryo and left in 
this solution to dissociate the cells and allow for plating. Approximately 30-40 minutes after 
isolation of the neural tube, dissociated cells were plated using a fire-pulled Pasteur pipette in 
3mL of Xenopus Defined Medium (XenDM; 50% L-15, 49% Ringer’s solution and 1% Fetal 
Bovine Serum (FBS) pH=7.6; supplemented with Antibiotic and Antimycotic [1mL/100mL]). 
All-trans retinoic acid was added to a final bath concentration of 10
-7
M in order to promote 
outgrowth for all growth cone assays. The experiments assessing the neurotrophic effects of 
retinoic acid had either all-trans or 9-cis retinoic acid (10
-7
M) added to the culture dish which 
was compared to the outgrowth seen in dishes where only vehicle (EtOH; 0.001% in bath) was 
added.  Cells were incubated in each condition for approximately 18 hours before being assessed 
for outgrowth. Neurites were only measured when the cell could be identified as a neuron based 
on morphology. 
 
2.03 Lymnaea Conditioned Medium (CM) Preparation:  
CM was prepared by dissecting 12 Lymnaea CNSs from animals ranging in size from 20-
30mm. CNSs were then passed through a series of 20 antibiotic saline (ABS, 225µg/ml 
gentamicin; Sigma-Aldrich) washes, which was repeated prior to each incubation period. The 
CNSs were then incubated in 7mL of DM at RT and CM produced from incubation periods from 
day 3-7 or 7-11 were used for cell culture experiments. All CM was checked for contamination 
prior to use, using an inverted microscope (Zeiss Axiovert 200, 20X and 40X) and discarded if 
compromised.     
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2.04 Growth Cone assays: 
Lymnaea: 
Approximately 18-20 hours following plating of cells, neurons were checked for 
outgrowth and individual growth cones assessed for active growth prior to the initiation of these 
experiments. Only growth cones actively growing were used for subsequent assays. A growth 
cone was monitored for 20 minutes to ensure continued growth and a steady trajectory. All 
retinoids and chemicals were applied at 10
-5
M when in the pipette. Test agents included all-trans 
and 9-cis retinoic acid, PA024 (RXR agonist), TTNPB (RAR agonist; Tocris Bioscience) and 
DMSO (vehicle control). These agents were applied to the growth cones using a pressure pipette 
(Eppendorf-Femtojet). The pipette was placed between 50 and 150 µm from the growth cone 
depending on both the size of the pipette opening (range = 4-8 µm) and the pressure applied (3-
10 hPa). Previous work using pipette assays by Lohof et al. (1992) showed that the chemical was 
at a concentration 100-1000 times less at the growth cone compared to its concentration at the 
pipette. Therefore the concentration of the agent reaching the growth cone is estimated to be 
between 10
-7
 and 10
-8
 M. Growth cone turning assays lasted 1 hour and growth cone movement 
was monitored and photographed throughout (Northern Eclipse imaging software; Empix 
imaging, ON).  
 
Xenopus: 
Cultured spinal neurons were identified based on well-established morphology (Tabti et 
al. 1998; Undumatla and Szaro, 2001), as the cultures were heterogeneous and contained a 
variety of neuronal and non-neuronal cell types. In short, cells which displayed a tubular soma 
and bipolarity were identified as muscle cells and were excluded from these studies. In contrast, 
cells which displayed a spherical soma with multiple projections (neurites) from the cell body 
and a similar morphology to a regenerating neuron seen in Lymnaea cultures, were identified as 
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neurons and used for experiments (See Figure 5). All Xenopus growth cone turning assays were 
performed in the same way as previously described for Lymnaea growth cones.  
 
Figure 5. Representative images depicting the morphology of a muscle cell (A) and a neuron (B) 
in a heterogeneous culture of Xenopus neural tube cells. Scale bar = 15 µm 
 
 
 
2.05 Chemicals: 
Both all-trans and 9-cis retinoic acid (Sigma-Aldrich) were initially dissolved in 100% 
EtOH and diluted to a final concentration of 10
-5
M in DM in a final EtOH concentration of 0.1% 
which was added to the pipette. Focal application of EtOH alone to growth cones has been 
shown previously not to elicit positive growth cone turning in Lymnaea neurons, so no EtOH 
controls were repeated in these studies (Dmetrichuk et al. 2006; Dmetrichuk et al. 2008; Farrar et 
al. 2009). The RXR pan-agonist PA024 and RAR agonist TTNPB were both dissolved in 100% 
DMSO and diluted to a final concentration of 10
-5
M in DM and added to the pipette (0.1% 
DMSO in pipette). In addition, the RXR antagonist HX531 and RAR antagonist LE540 were 
dissolved in DMSO and diluted to produce a final bath concentration of 10
-6
M for both Lymnaea 
and Xenopus experiments. DMSO was diluted to a concentration of 0.1% in DM and applied via 
a pipette (as controls for agonists in the growth cone turning assays). During retinoic acid 
antagonist experiments, DMSO was added to the dish for a final bath concentration of 0.01% (to 
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control for vehicle in antagonist experiments). In the Xenopus studies, the RARβ antagonist, 
LE135, was dissolved in DMSO and diluted to a final bath concentration of 10
-6
M (PA024, 
HX531, LE540 and LE135 were a kind gift from Dr. H Kagechika. Tokyo). 
 
2.06 Immunostaining: 
Lymnaea: 
Following the completion of the growth cone assays, cultured neurons were fixed in 4% 
paraformaldehyde in Phosphate Buffered Saline (PBS) at 4°C overnight. The fixed cells were 
washed in PBS and then permeabilized in 0.3% Triton X-100 in PBS (PBT) for 20 min and 
blocked in 5% normal goat serum (NGS) in PBT overnight at RT.  The samples were then 
incubated with the primary anti-LymRXR antibody diluted 1:100 in blocking solution at 4
o
C 
overnight. The antibody was designed against a synthetic peptide from the predicted ‘hinge’ 
region of the Lymnaea RXR, covering the amino acid residues 183-198 between the DNA 
binding domain (DBD) and ligand binding domain (LBD). This custom made LymRXR antibody 
was produced in New Zealand white rabbits and affinity purified from the antisera by Pacific 
Immunology Corp. (Ramone, California, USA).  As a control, preparations were also incubated 
only in blocking solution, without the primary antibody, at 4
o
C overnight. All samples were then 
washed 3 times in PBT for 5 minutes and incubated in 1:500 dilution of Alexa Fluor 488 goat 
anti-rabbit secondary antibody (Invitrogen) in blocking buffer at RT for 2 hours. The samples 
were washed 3 times in PBT for 5 min and counterstained with 4',6-diamidino-2-phenylindole 
(DAPI; Sigma-Aldrich) for 2 min to visualize the nuclei. 
Xenopus: 
For immunostaining of cultured Xenopus spinal neurons, the same protocol employed for 
Lymnaea cells was used. However, to visualize the expression of RARβ2, a Notopthalmus 
viridescens RARβ2-specific antibody diluted 1:100 was used as the primary antibody. The 
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antibody was designed against a synthetic peptide from the predicted ‘hinge’ region of the 
NvRARβ2 covering the amino acid residues 175-188, between the DNA binding domain (DBD) 
and ligand binding domain (LBD). This custom made polyclonal NvRAR β2 antibody was 
produced in New Zealand white rabbits and affinity purified from the antisera by Pacific 
Immunology Corp. 
2.07 Analysis: 
All images were captured using a Zeiss Axiovert 200 inverted microscope, Q imaging 
Retiga Exi camera and Northern Eclipse software (Empix Imaging, ON).  Individual growth 
cone turning angles were determined by measuring the angle between the growth cone's initial 
trajectory and the maximum angle of turning observed over the course of the experiment.  
Images were taken every 3-4 minutes over the course of each growth cone turning assay.  A 
positive turning response was deemed to have a turning angle towards the pipette and a negative 
response had an angle away from the pipette. All statistical analyses were performed using 
SigmaStat software. Data from experiments using 9-cis RA were analyzed using a 1-way 
ANOVA and a Tukey-Kramer post-hoc test was used to determine statistical significance.  An 
ANOVA on ranks was performed on data from experiments using all-trans RA followed by a 
Bonferroni-Dunns post-hoc test as this data set failed normality. In addition, a t-test was 
performed on data from experiments using TTNPB and PA024 as these separate experiments 
consisted of only two data sets. In addition, all data sets performed with Xenopus were analyzed 
using a 1-way ANOVA followed by a Tukey-Kramer post hoc. In addition, the length of any 
given neurite emerging from the cell body was calculated by taking the mean length of all its 
branched processes. The mean neurite length for each cell was then calculated by averaging the 
lengths of all neurites for that cell. Results are expressed as mean  standard error of the mean 
(SEM) and were deemed significant when p<0.05. 
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Chapter 3.1: Results 
The role of the RXR and novel, non-chordate RAR in 
retinoic acid-mediated chemoattraction in the pond snail, 
Lymnaea stagnalis 
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In the CNS of adult Lymnaea, both all-trans RA and 9-cis RA isomers are found to be 
present, at relatively equal concentrations (Dmetrichuk et al. 2008). Furthemore, studies on the 
effects of RA on growth cone behaviour in our lab have previously shown that these two RA 
isomers exert very similar effects on the growth cones (Dmetrichuk et al. 2006; Dmetirchuk et 
al. 2008; Farrar et al. 2009). Both all-trans and 9-cis exert positive growth cone turning with 
very similar turning angles. Carter et al. (2010) previously investigated the potential role of the 
RXR in mediating the response of RA. They showed that the RXR pan-agonist, PA024, could 
mimic the effects of both all-trans and 9-cis RA and that the RXR agonist repsonse was blocked 
by the RXR antagonists, PA452 and HX531. This previous study did not however go as far as to 
test whether the RXR antagonist was able to block the growth cone turning responses to both all-
trans and 9-cis isomers. Therefore, the first aim of my thesis was to determine the role that the 
RXR may play in growth cone behaviour induced by the known endognenous isomers, all-trans 
and 9-cis RA.  
3.11 The RXR antagonist HX531 blocked 9-cis retinoic acid-induced positive growth cone 
turning. 
  As 9-cis RA is the natural ligand for the RXR in vertebrates and is known to also bind the 
RXR in invertebrates (Kastner et al. 1995; Nowickyj et al. 2008), I first sought to determine if 
the RXR plays a role in the growth cone turning induced by 9-cis retinoic acid. To test this, a 
local gradient of 9-cis retinoic acid (10
-5
M) was applied to an advancing growth cone in the 
presence of either the RXR antagonist HX531 (10
-6
M in bath), or in the presence of DMSO 
(0.01% in bath) as a vehicle control. Growth cone turns toward RA are depicted as a positive 
turning angle in the histograms whereas growth cone turns away from RA are depicted as a 
negative turning angle. Growth cones were found to turn toward the source of 9-cis retinoic acid 
in the presence of DMSOwith a mean turning angle of 33.9 + 2.6° (n=8) (Figure 6Ai-iii). In 
contrast, when a gradient of 9-cis retinoic acid was applied in the presence of the RXR 
antagonist, HX531,  positive growth cone turning was blocked, with a mean turning angle of -
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20.1 + 12.4° (n=7) (Figure 6Bi-iii). A histogram showing maximum turning angles of each 
individual growth cone in response to 9-cis retinoic acid in the presence of DMSO or HX531 is 
shown in Figure 6Aiii and Biii respectively. There was a significant difference between the mean 
turning angle towards 9-cis retinoic acid in DMSO compared to HX531 (p<0.001) (Figure 7). 
Because the RXR pan-antagonist HX531 was able to block 9-cis RA-induced growth cone 
turning, these data suggest that the RXR plays an important role in mediating 9-cis RA-induced 
growth cone guidance. 
3.12 The RXR antagonist HX531 blocked all-trans retinoic acid-induced positive growth 
cone turning. 
Although it is thought that 9-cis retinoic acid is the natural ligand for the RXR, at least in 
vertebrates, recent literature suggests all-trans RA may also bind to the RXR in invertebrates. 
Nowickyj et al. (2008) showed that both isomers, 9-cis and all-trans retinoic acid bind to the 
locust RXR with equal affinity. It is then possible that the RXR mediates the response to both 
naturally occuring isomers. Therefore I sought to determine whether this receptor also mediates 
all-trans RA-induced growth cone turning. I tested this idea by applying a local gradient of all-
trans RA (10
-5
M) to an advancing growth cone in the presence of either the antagonist vehicle 
control DMSO or the RXR antagonist HX531. Growth cones were found to turn toward the 
source of all-trans retinoic acid in the presence of DMSO (0.01% in bath) with a mean turning 
angle of 31.5 + 2.4° (n=8) (Figure 8Ai-iii). In contrast, when a gradient of all-trans retinoic acid 
was applied in the presence of the RXR antagonist HX531 (10
-6
M in bath),  positive growth cone 
turning was blocked, with a mean turning angle of -5.8 + 9.2° (n=11) (Figure 8Bi-iii). A 
histogram showing maximum turning angles of each individual growth cone in response to all-
trans retinoic acid in the presence of DMSO or HX531 is shown in Figure 8Aiii and Biii. 
Although, four of eleven growth cones showed a positive turn toward RA in the presence of 
HX531, the overall mean turning angle was significantly less than the mean turning angle toward 
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all-trans retinoic acid in DMSO (p<0.05) (Figure 9). These data suggest that the RXR may also 
mediate the growth cone turning toward all-trans RA, as well as to 9-cis RA.  
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Figure 6. Lymnaea growth cones were attracted to a gradient of 9-cis retinoic acid and this 
response was blocked by the RXR antagonist, HX531. Representative images depicting the 
response of a growth cone to a local gradient of 9-cis retinoic acid in the absence (Ai-ii; DMSO) 
or presence of HX531 (Bi-ii). The pipette tip is outlined in the upper right hand corner of Ai-Bii.  
Aiii and Biii. Histograms showing the individual maximum turning angles toward the source of 
9-cis retinoic acid in DMSO or HX531. (Times (t) are given in minutes. Scale bars = 15µm).  
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Figure 7. The RXR antagonist, HX531, blocked 9-cis retinoic acid induced positive growth 
cone turning. Summary graph showing the mean maximum turning angle exhibited by the 
growth cones in response to 9-cis retinoic acid in the presence of the vehicle control DMSO 
compared to the RXR antagonist HX531. A statistically significant difference is present between 
the two conditions, *** p<0.001, 1-way ANOVA. Error bars represent the standard error of the 
mean (SEM). 
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Figure 8. All-trans retinoic acid-mediated growth cone turning is blocked by the RXR 
antagonist, HX531. Ai-ii. Representative images depicting the turning response of a growth 
cone in response to a local gradient of all-trans retinoic acid in the presence of the vehicle 
control DMSO. Bi-ii. The RXR antagonist HX531 blocked all-trans retinoic acid-induced 
growth cone turning. The pipette tip is shown in upper right hand corner in Bii and the 
approximate location is illustrated otherwise. Aiii and Biii. Histograms showing the maximum 
turning angles of each individial growth cone toward all-trans RA in either DMSO or HX531. 
(Times (t) are given in minutes. Scale bar = 15µm).  
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Figure 9. The RXR antagonist blocked all-trans retinoic acid induced positive growth cone 
turning. Summary graph showing the mean turning angles exhibited by the growth cones in 
response to all-trans retinoic acid in the presence of the vehicle control, DMSO (0.01%), or the 
RXR antagonist, HX531 (10
-6
M). A statistically significant difference is present between the two 
conditions, * p<0.05, ANOVA on ranks. Error bars represent the standard error of the mean 
(SEM). 
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3.13 RXR is present in the growth cones of cells regardless of their response to a gradient of 
either retinoic acid or the RXR agonist, PA024. 
Carter et al. (2010) previously showed the presence of RXR in growth cones of PeA 
neurons and evidence from neurites isolated from the cell body, suggests that local activation of 
the RXR (by RA or by an RXR agonist) is sufficient to produce the growth cone response. 
However, this article also showed that a small number of growth cones (7 of 102) did not exhibit 
RXR immunoreactivity. These data raise the possibility that in this study, some growth cones 
may not have responded to the retinoids due to the absence of the RXR. To rule out this 
possibility, growth cones that failed to respond to RA in the presence of HX531 (RXR 
antagonist) were immunostained to confirm the presence of RXR. Growth cones that turned 
toward the RXR pan-agonist, PA024, were used as positive controls. Growth cones that showed 
positive turning to PA024 did indeed show immunoreactivity for RXR (n = 8; Figure 10Ai-ii) as 
indeed did those growth cones that failed to respond to all-trans RA (n = 4) or 9-cis RA (n = 4) 
in the presence of HX531 (Figure 10Bi-ii). In contrast, cells used as controls that were labelled 
with only the secondary antibody showed no immunofluorescence (n = 10; data not shown). 
These data suggest that the lack of a growth cone turning response is not because the RXR is 
absent from the growth cone, but due to the presence of the RXR pan-antagonist, HX531, which 
is blocking the positive growth cone turning response exerted by RA (n = 16). 
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Figure 10. Lymnaea RXR is present in growth cones that do not respond to all-trans RA in 
the presence of HX531. Phase contrast images showing the endpoint of the growth cone assays 
prior to cell fixing (Ai-Bi). Immunostaining shows the RXR (green) to be present in the neurite 
and growth cone of a cell which turned towards a gradient of the RXR agonist PA024 in the 
vehicle control DMSO (Aii; n = 8)) and a growth cone which did not turn towards a gradient of 
all-trans retinoic acid in the presence of the RXR antagonist HX531 (Bii; n = 4). Note the lack of 
immunostaining in the control which lacked the primary antibody (Ci-ii). (Times (t) are given in 
minutes. Scale bars = 15 µm). 
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The data shown thus far suggest that both all-trans and 9-cis RA isomers might act via 
the RXR to mediate growth cone turning. However, it is known from vertebrate binding studies 
that both these RA isomers also bind to the RAR. Until recently, no RARs had been identified in 
non-chordates. However, Carter (2011) recently cloned the first non-chordate RAR, showing its 
expression in embryo, adult CNS and regenerating neurons in culture. Interestingly, like the 
RXR, RAR also showed non-nuclear distribution in adult neurons, with RAR immunoreactivity 
found in neurites and growth cones. This evidence raises the possibility that all-trans and 9-cis 
RA might also exert their chemoattractive effects to produce growth cone turning via the RAR. It 
was therefore my next aim to determine the role of this novel RAR in chemoattraction and to 
determine if it mediates retinoic acid-induced growth cone turning in Lymnaea neurons. 
3.14 The RAR antagonist LE540 blocked all-trans retinoic acid-induced growth cone 
turning. 
No previous studies have examined the role of RAR in growth cone turning, therefore I 
assessed the role of the novel, non-chordate RAR in RA-mediated chemoattraction. First, I set 
out to determine whether this receptor mediates RA-induced growth cone turning by performing 
a growth cone assay and applying a local gradient of all-trans retinoic acid (10
-5
M in pipette) in 
the presence of the RAR pan-antagonist, LE540 (10
-6
M in bath). Previous evidence from Carter 
(2011) shows that this concentration of LE540 exerts effects on Lymnaea development. When 
all-trans retinoic acid was applied in the presence of the RAR antagonist LE540, positive growth 
cone turning was blocked, producing a mean turning angle of -11 + 5.8° (n=10) (Figure 11Bi-iii).  
The mean turning angle for all-trans retinoic acid in the presence of DMSO (0.01% in bath) was 
31.5 + 2.4° (n=8) (Figure 11Ai-iii). Histograms illustrating the maximum turning angle of each 
individual growth cone in response to all-trans retinoic acid in the presence of DMSO or LE540 
are shown in Figure 11Aiii and Biii. Note that the control data set for all-trans RA applied in the 
presence of DMSO is the same as that shown in Figures 8 and 9 and is shown again here as a 
comparison to the antagonist data set. As stated previously, in the presence of DMSO, 8 of 8 
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growth cones turned toward all-trans RA with a mean turning angle of  31.5 + 2.4° (Figure 9). 
However, in the presence of LE540, only 2 of 10 showed positive turning and the overall mean 
turning angle of -11 + 5.7° was significantly less compared to all-trans RA in DMSO (p<0.05) 
(Figure 12).  
3.15 9-cis retinoic acid-induced growth cone turning was blocked by the RAR antagonist 
LE540. 
Previous evidence has shown that 9-cis RA binds to both the RXR and RAR in 
vertebrates with almost equal affinity (Maden, 2007). Therefore, I next aimed to determine if the 
RAR mediates 9-cis retinoic acid-induced turning. Interestingly, when 9-cis retinoic acid was 
applied in the presence of the RAR antagonist LE540, positive growth cone turning was once 
again blocked (mean turning angle of -28.4 + 5.9° (n=11)) (Figure 13Bi-iii). These data were 
compared to 9-cis retinoic acid in the presence of DMSO which elicited a mean turning angle of 
33.9 + 2.6° (n=8) (Figure 13Ai-iii). A histogram illustrating the maximum turning angles of each 
individual growth cone in response to 9-cis retinoic acid in the presence of DMSO or LE540 is 
shown in Figure 13Aiii and Biii. Note that although a different representative image has been 
shown in Figure 13, the control growth cone turning data in response to 9-cis RA in DMSO are 
the same as those presented in Figures 6 and 7 and are shown again here for the purpose of 
comparison. There was a significant difference between the mean turning angle towards 9-cis 
retinoic acid in DMSO compared to LE540 (p<0.001) (Figure 14). In summary, the RAR pan-
antagonist, LE540, blocked positive growth cone turning elicited by both all-trans and 9-cis 
retinoic acid, suggesting a role for the RAR, in addition to the RXR, in RA-mediated 
chemoattraction.  
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Figure 11. Lymnaea growth cones were attracted to a gradient of all-trans retinoic acid and 
this response was blocked by the RAR pan-antagonist, LE540. (Ai-ii) Representative images 
depicting the turning response of a growth cone to a local gradient of 9-cis retinoic acid in the 
vehicle control DMSO. This response was inhibited in the presence of the RAR antagonist 
LE540 (Bi-ii). The pipette tip is outlined  in the upper right hand corner of Ai-ii and Bi.  Aiii and 
Biii. Histograms showing the individual maximum turning angles toward the source of retinoic 
acid. (Times (t) are given in minutes. Scale bars = 15µm). Note that the same control data for 
DMSO were used for comparison in this case as in Figures 8 and 9. 
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Figure 12. The RAR antagonist, LE540 blocked all-trans retinoic acid-induced positive 
growth cone turning. Summary graph showing the mean maximum turning angle exhibited by 
the growth cones in response to all-trans retinoic acid in the presence of the RAR antagonist 
LE540 compared to vehicle control (DMSO). A statistically significant difference was present 
between the two conditions, * p<0.05, ANOVA on ranks. Error bars represent the standard error 
of the mean (SEM). 
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Figure 13. Positive growth cone turning responses to a gradient of 9-cis retinoic acid were 
blocked by the RAR antagonist, LE540. (Ai-ii) Representative images depicting the turning 
response of a growth cone to a local gradient of 9-cis retinoic acid in the vehicle control DMSO. 
This response was blocked in the presence of the RAR antagonist LE540 (Bi-ii). Pipette depicted 
in the upper right hand corner of Ai and Bi.  Aiii and Biii. Histograms showing the individual 
maximum turning angles toward the source of retinoic acid. (Times (t) are given in minutes. 
Scale bars = 15µm).  
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Figure 14. The RAR antagonist, LE540 blocked 9-cis retinoic acid-induced positive growth 
cone turning. Summary graph showing 9-cis retinoic acid-induced mean turning angles of 
growth cones in the presence of the vehicle control DMSO or the RAR antagonist LE540. The 
overall mean turning angle elicited by 9-cis RA in the presence of LE540 was significantly less 
compared to 9-cis RA in DMSO. *** p<0.001, 1-way ANOVA. Error bars represent the standard 
error of the mean (SEM). 
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3.16 The RAR antagonist does not block the RXR agonist, PA024, induced growth cone 
turning.  
The data shown above suggest the LymRAR may play a role in the RA-induced growth 
cone turning response. However, LymRAR shows less similarity to vertebrate RARs (~58% 
homology in LBD) than the LymRXR does to vertebrate RXRs (~80% homology in LBD). This 
raises the possiblity that the vertebrate RAR pan-antagonist, LE540, is not selective for LymRAR 
and as this is the first non-chordate RAR cloned, no binding assays have yet been performed. My 
next aim was therefore to test the selectivity of the pan-RAR anatagonist, LE540, by testing its 
effects on the growth cone turning response to the applied RXR pan-agonist, PA024. Carter et al. 
(2010) previously showed that RXR pan-agonist turning response was blocked by the RXR 
anatgonist, but the RAR antagonist has not been tested previously. Furthermore, evidence 
indicates that LE540 can also bind RXRs, but is less able to inhibit these compared to RARs 
(Umemiya, 1997). The RAR pan-antagonist, LE540, was designed against the vertebrate RAR 
and therefore the selectivty for the Lymnaea RAR is unknown. Therefore, in order to investigate 
potential non-selective actions of LE540 or cross-reactivty with RXR, I examined whether the 
RAR-selective antagonist, LE540, is able to block a selective RXR agonist, PA024-induced 
growth cone turning.  
A local gradient of PA024 (10
-5
M in pipette) was applied to an advancing growth cone 
and it induced  positive growth cone turns with a mean turning angle of 25.3 + 4.4° (n=9) (Figure 
15Ai-iii). Likewise, when PA024 was applied in the presence of the RAR antagonist LE540, the 
RXR agonist was still able to induce a positive turning angle with a mean angle of 24.7 + 5.5° 
(n=11) (Figure 15Bi-iii). Histograms illustrating the maximum turning angle of each individual 
growth cone in response to PA024 in the presence of either DMSO or LE540, are shown in 
Figure 15Aiii and Biii. There was no significant difference between the application of PA024 
alone or in the presence of LE540 (Figure 16). These data suggest that the RXR agonist, PA024, 
was able to induce growth cone turning in the presence of the RAR antagonist, LE540, which 
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suggests the binding of these chemicals to their respective receptors may be relatively selective 
(though binding studies would be required to verify this statement).  
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Figure 15. Intact growth cones were attracted to a gradient of the RXR agonist PA024 in 
the presence of the RAR antagonist LE540. (Ai-ii) Representative images depicting the 
turning response of a growth cone to a local gradient of PA024 in the presence of DMSO or the 
RAR antagonist LE540 (Bi-ii). The pipette tip is shown in the bottom (Ai-Aii) and upper (Bi-Bii) 
right hand corner. Aiii and Biii. Histograms showing the individual maximum turning angles 
toward PA024. (Times (t) are given in minutes. Scale bars = 15µm).  
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Figure 16. The RAR antagonist LE540 did not block the RXR agonist, PA024-induced 
growth cone turning. Summary graph showing nearly identical mean turning angles exhibited 
by growth cones in response to PA024 in the presence of DMSO or the RAR antagonist LE540. 
No statistically significant difference was found between the two conditions (p>0.05, t-test). 
Error bars represent the standard error of the mean (SEM). 
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3.17 The RAR agonist TTNPB does not induce positive growth cone turning 
 The inability of the RAR antagonist LE540  to block the RXR agonist, PA024-induced 
growth cone turning, suggests that the two receptors may be acting independently from one 
another to mediate this response, but more specifically provides evidence that less cross-
reactivity of agonists and antagonists is present. Therefore, I next aimed to determine whether 
the RAR-selective agonist, TTNPB (10
-5
M in pipette) was sufficient to elicit a positive growth 
cone turning response when compared to the focal application of the vehicle control DMSO 
(0.1% in pipette). However, it should be noted that TTNPB was designed against the vertebrate 
RAR  and has previously been shown to have similar IC50s to all-trans RA, the natural ligand for 
RARs, based on competitive binding assays in mice (Pignatello et al. 1999). In addition, 
Pignatello et al. (1999) showed that TTNPB had no appreciable affinity for any of the RXR 
subtypes. A local gradient of DMSO was applied to an advancing growth cone and it was 
determined that this control assay did not induce positive growth cone turning (mean turning 
angle of -8.3 + 6.4°; n=10) (Figure 17Ai-iii). When the RAR agonist TTNPB was applied in the 
same fashion, it also did not induce positive turning (mean turning angle of -7.1 + 7.7°; n=15) 
(Figure 17Bi-iii). A histogram illustrating the maximum turning angle of each individual growth 
cone in response to DMSO or TTNPB is shown in Figure 17Aiii and Biii. There was no 
significant difference in mean turning angles between the application of DMSO and TTNPB 
(Figure 18). This evidence suggests that either activation of the RAR is not sufficient to induce 
growth cone turning or that TTNPB is not activating the Lymnaea RAR. Looking at the 
individual growth cone turning angles however, TTNPB appeared to elicit a larger variance in 
turning angles whereas DMSO controls showed little or no response either towards or away from 
the DMSO source (with the exception of 1 growth cone). We do not currently know enough 
about the Lymnaea RAR sequence to predict that TTNPB will bind to it, therefore binding 
studies will be required to fully elucidate the effects of TTNPB. 
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Figure 17. Pedal A growth cones did not turn toward the RAR agonist TTNPB. 
Representative images depicting the turning response of a growth cone in response to a local 
gradient of DMSO (Ai-ii) or the RAR agonist TTNPB (Bi-ii). Aiii and Biii. Histograms showing 
the individual maximum turning angles toward or away from DMSO or TTNPB. The pipette tip 
is illustrated in the upper right hand corner (Ai-Bii). (Times (t) are given in minutes. Scale bar = 
15µm).  
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Figure 18. The RAR agonist TTNPB was not able to induce positive growth cone turning 
compared to the DMSO control. Summary graph showing the mean maximum turning angle 
exhibited by the growth cones in response to DMSO or the RAR agonist TTNPB. No statistical 
significance was found between the mean turning angles elicited by DMSO compared to TTNPB 
(p>0.05, t-test). Error bars represent the standard error of the mean (SEM). 
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4.18 Summary 
The data shown here demonstrated that both the RXR and the newly cloned RAR are 
involved in growth cone turning in response to both endogenous RA isomers. I’ve also 
demonstrated that the lack of a turning response by some growth cones to a gradient of the RXR 
pan-agonist, PA024, was not due to the absence of the RXR in these particular growth cones. 
Furthermore, I’ve shown that the RXR pan-agonist and RAR pan-antagonist appear to have little 
cross-reactivity with the opposing retinoid receptor as PA024-induced growth cone turning was 
retained in the presence of LE540. Finally, I’ve shown that focal application of the RAR pan-
agonist, TTNPB, is insufficient to elicit the positive growth cone turning  that is seen with RA 
and PA024.    
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Figure 19. Summary graph showing the mean maximum turning angles of growth cones in 
various conditions. Statistical comparisons are made to the DMSO vehicle control groups. Error 
bars represent standard error of the mean (SEM). HX531 – RXR antagonist, LE540 – RAR 
antagonist, PA024 – RXR agonist, TTNPB – RAR agonist.* p<0.05, *** p<0.001.  
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Chapter 3.2: Results 
The conservation of retinoic acid’s neurotrophic and 
chemotropic role in the South African clawed frog, 
Xenopus laevis 
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3.21 Retinoic acid acts a neurotrophic factor for Xenopus embryonic spinal cord neurons, 
inducing significant neurite outgrowth of cultured neurons. 
As discussed above, the role of retinoic acid has been well documented in Lymnaea 
stagnalis in terms of its neurotrophic and chemotropic activities in vivo and in vitro (Dmetrichuk 
et al. 2006, Farrar et al. 2009 and Carter et al. 2010). However, our lab has previously shown 
that all-trans retinoic acid is capable of inducing significant neurite outgrowth from cultured 
newt spinal cord explants (Dmetrichuk et al. 2005). In addition, retinoic acid has previously been 
implicated in axonal guidance in cultured chick neural tube cells (Maden et al. 1998). Based on 
this evidence, we wanted to determine if RA acts as a chemotropic molecule to induce individual 
growth cone turning in vertebrate neurons. We chose to perform these growth cone assays 
experiments with the South-African clawed frog, Xenopus laevis. These embryos are easily 
obtained and previous literature has shown the capacity for isolation of the neural tube and 
dissociation of spinal cord neurons to allow for growth cone assays to be performed on 
individual growth cones. Furthermore, RA has not previously been shown to exert effects in 
these neurons. However, I also wished to determine if RA could exert neurotrophic effects on 
embryonic spinal cord neurons first, as has been shown in many other vertebrate embryonic 
neurons. Hence, my first aim was to look at the potential neurotrophic effects of both isomers, as 
has been shown previously in the newt (Dmetrichuk et al. 2005; Rand, 2009, Zeglinski, 2008) on 
cultured embryonic spinal cord neurons from the stage 22 Xenopus embryo. 
Spinal cord neurons were cultured from the stage 22 embryo and plated in DM. Retinoic 
acid (all-trans and 9-cis) was added to the media at 10
-7
M (bath concentration) while EtOH, 
acting as the vehicle control, was added at 0.001% (bath concentration). Ethanol induced a mean 
neurite length of 20  m + 1.2 (n=192) (Figure 20A). In contrast, all-trans retinoic acid induced a 
mean neurite length of 34.5 µm + 1.6 (n=376) (Figure 20B). In addition, 9-cis retinoic acid 
induced a mean neurite length of 33.2 µm + 2.8 (n=113) (Figure 20C).  Statistical analysis 
revealed that both isomers of retinoic acid induced significantly longer mean neurite lengths of 
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cells identified as neurons compared to the vehicle control (p<0.05; Figure 20D). In addition, the 
number of neurons which survived and extended neurites (and therefore were capable of being 
identified as neurons based on morphology), in all-trans retinoic acid, 9-cis retinoic acid or 
EtOH was 84, 77 and 39 respectively, over the same number of dishes. 
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Figure 20. Cultured Xenopus embryonic spinal cord neurons had significantly more 
outgrowth in the presence of either all-trans or 9-cis retinoic acid when compared to the 
ethanol control. Representative images of Xenopus embryonic spinal cord neurons cultured in 
EtOH (0.001%; Ai-ii), all-trans retinoic acid (10
-7
M; Bi-ii) or 9-cis retinoic acid (10
-7
M; Ci-ii). 
D) Histogram showing mean neurite length of individual cultured embryonic spinal neurons in 
each condition indicating a trophic role for RA. Scale bar = 15 µm. Error bars represent standard 
error of the mean (SEM). *p<0.05, 1-way ANOVA. 
65 
 
3.22 RARβ mediates the chemoattractive activity of all-trans retinoic acid for Xenopus 
embryonic spinal cord cells in vitro. 
The data shown in Figure 20 demonstrate RA’s neurotrophic conservation in these 
vertebrate neurons. Therefore, I next aimed to determine whether RA could act as a chemotropic 
molecule and induce growth cone turning of cultured spinal cord neurons. After approximately 
18-20 hours in vitro in 10
-7
M all-trans RA (bath concentration), spinal cord cultures were 
checked for outgrowth and neurons were identified based on their morphology (previously 
described in the Methods, Figure 5). A local gradient of EtOH (0.1% in pipette) was applied 
using a pressure pipette to an advancing growth cone and did not induce growth cone turning 
(mean turning angle of 1.1 + 4.6°) (n=7) (Figure 21Ai-iii). In contrast, focal application of all-
trans retinoic acid (10
-5
M) elicited a positive growth cone turn with a mean turning angle of 32.9 
+ 3.3° (n=8) (Figure 21Bi-iii). In order to assess which receptor may mediate this response to all-
trans RA, I first decided to use the RARβ-selective antagonist, LE135, as prevous data from our 
lab showed that this antagonist was able to block neurite outgrowth elicited by all-trans retinoic 
acid from cultured newt spinal cord explants (Dmetrichuk et al. 2005). Interestingly, when all-
trans retinoic acid was applied in the presence of  LE135, positive growth cone turning was 
blocked with a mean turning angle of  -21.6 + 4.6° (n=7) (Figure 21Ci-ii). Histograms showing 
maximum turning angles of individual growth cones in response to EtOH, all-trans retinoic acid 
alone or in the presence of LE135 are shown in Figure 21 Aiii-Ciii. When the overall mean 
turning angle elicited by EtOH was compared to all-trans RA, it was found that all-trans RA 
induced a significantly larger turning angle compared to EtOH (p<0.001) (Figure 23), and that 
this response to RA was signficantly reduced in the presence of LE135 (p<0.001) (Figure 23). 
Note that four growth cones assays were performed in DM alone (mean = 29.6°) and three 
growth cone assays were performed in the presence of DMSO (mean = 38.3°) suggesting DMSO 
had was not responsible for the decrease in mean turning angle in response to all-trans RA in the 
presence of LE135. These data show for the first time, that all-trans RA-induced growth cone 
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turning may be conserved in vertebrate neurons and suggest that RARβ may be mediating the 
all-trans RA-induced chemoattraction of Xenopus embryonic vertebrate neurons. 
3.23 RXR mediates the growth cone turning induced by 9-cis retinoic acid of Xenopus 
embryonic spinal cord cells. 
We next aimed to assess whether the RA isomer, 9-cis retinoic acid, was able to induce 
growth cone turning as it has previously been shown to do so in cultured Lymnaea neurons 
(Carter et al. 2010). As in the invertebrate model, when a gradient of 9-cis RA was applied, 
Xenopus growth cones turned towards the source of 9-cis RA with a mean turning angle of 34.8 
+ 6.9° (n=8) (Figure 22Ai-ii). Because 9-cis RA is a natural ligand for the RXR (even though it 
also binds to RAR), we decided to assess the RXR’s role in mediating this response to 9-cis RA. 
As hypothesized, when 9-cis RA was applied in the presence of the RXR antagonist, HX531, 
positive turning was blocked (mean turning angle of -8.3 + 3.6°) (n=6) (Figure 22Bi-ii). 
Histograms showing maximum turning angles of individual growth cones in response to 9-cis 
retinoic acid alone or in the presence of HX531 is shown in Figure 22 Aiii-Biii. When taken 
together, the overall mean turning angle induced by 9-cis RA was significantly higher than focal 
application of EtOH (p<0.001). Furthermore, when the RXR antagonist, HX531, was present in 
the bath, 9-cis RA-induced growth cone turning was significantly reduced (p<0.001) (Figure 23). 
Note that four growth cones assays were performed in DM alone (mean = 27°) and four growth 
cone assays were performed in the presence of DMSO (0.01% in bath; mean = 42.5°) suggesting 
DMSO was not responsible for the decrease in mean turning angle in response to 9-cis RA in the 
presence of HX531. These data show for the first time, in a vertebrate model, the conservation of  
9-cis retinoic acid-induced growth cone turning of Xenopus embryonic spinal cord neurons and 
that this response may be mediated by the RXR.  
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Figure 21. Cultured Xenopus embryonic spinal cord neuron growth cones were attracted to 
a gradient of all-trans retinoic acid and the RARβ antagonist LE135 blocked all-trans RA 
induced turning. Representative images depicting the turning response of a growth cone in 
response to a local gradient of EtOH (n=7) (Ai-ii), all-trans retinoic acid (n=8) (Bi-ii) and all-
trans retinoic acid in the presence of the RARβ-selective antagonist LE135 (n=7) (Ci-ii). 
Histograms showing the individual maximum turning angles toward the pipette (Aiii-Ciii). The 
pipette tip location is illustrated on the right side of the representative images. Note that assays of 
three growth cones with all-trans RA applied were performed in the presence of DMSO (0.01%) 
and the other 4 were done in DM alone. (Times (t) are given in minutes. Scale bar = 15µm). 
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Figure 22. Xenopus growth cones were attracted to a gradient of 9-cis retinoic acid and the 
RXR antagonist HX531 blocked 9-cis RA induced turning. Representative images depicting 
the turning response of a growth cone to a local gradient of 9-cis retinoic acid (n=8) (Ai-ii) and 
9-cis retinoic acid in the presence of the RXR antagonist, HX531 (n=6) (Bi-ii). Histograms 
showing the individual maximum turning angles toward the pipette (Aiii-Biii). The pipette tip 
location is illustrated in the upper right hand corner of the representative images. Note that four 
growth cones with 9-cis RA applied were performed in the presence of DMSO (0.01%). (Times 
(t) are given in minutes. Scale bar = 15µm). 
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Figure 23. Summary diagram showing all Xenopus mean growth cone turning angle 
responses under various conditions. Statistical comparison are made between RA alone and 
the EtOH control group as well as between RA alone or in the presence of the retinoid receptor 
antagonists. LE135 – RARβ antagonist, HX531 – RXR antagonist.Error bars represent the 
standard error of the mean (SEM). *** p<0.001, 1-way ANOVA. 
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Farrar et al. (2009) and Carter et al. (2010) have previously shown a novel non-genomic 
role for retinoids in the invertebrate model, Lymnaea stagnalis, contrary to their classical role as 
nuclear receptors. They showed non-nuclear staining of the RXR in the cytoplasm, neurite and 
growth cone in these motorneurons. More recently, the novel non-chordate RAR has shown 
similar staining in cultured neurons (Carter, 2011).  In addition, Carter (2011) also showed non-
nuclear staining of a RARβ in the regenerating tail and spinal cord of the newt. However, non-
nuclear staining of RARβ has never been shown in individual cultured vertebrate neurons. 
Furthermore, there are a few examples of RAR acting non-genomically in vertebrates (Canon et 
al. 2004; Liao et al. 2004; Poon and Chen, 2008). Therefore, my next aim was to investigate the 
localization of RARβ in embryonic spinal cord neurons from Xenopus laevis using 
immunocytochemistry. 
3.24 Immunostaining revealed non-nuclear staining of the vertebrate RARβ in cultured 
embryonic spinal cord neurons. 
 Following growth cone assay experiments, the Xenopus spinal neurons were fixed and 
stained for RARβ and also for DAPI to visualize the cell nucleus. A control antibody solution, 
which lacked the primary antibody which would bind RARβ, was applied to some dishes (n = 6) 
to ensure there was no immunoreactivity from the secondary antibody alone. As expected no 
immunoreactivity was found in any of these dishes. For the first time, I showed non-nuclear 
staining of the RARβ in Xenopus embryonic spinal cord neurons, where the antigen was 
localized in the cytoplasm, neurite and growth cone of vertebrate neurons (n=10; Figure 24A and 
B), similar to that of Lymnaea neurons.  This finding, combined with the blocking of all-trans 
retinoic acid-induced growth cone turning by LE135, suggest a novel non-genomic role for this 
receptor in mediating the effects of RA on outgrowth, survival and regeneration in the vertebrate 
CNS, although further experiments must be done to confirm this. 
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Figure 24. RARβ is present within the cytoplasm, neurite and growth cone of cultured 
Xenopus embryonic spinal cord neurons. A phase contrast image of a fixed spinal cord neuron 
(A) and the immunohistochemical staining for the vertebrate RARβ (green) and DAPI (Nuclear; 
Blue; B) (n = 10). Scale bars = 15 µm. Arrows indicate staining present in the growth cone 
which is magnified to show more clearly the immunostaining of RARβ within the growth cone 
(C). 
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Chapter 4: Discussion 
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In this study, I have provided evidence using cultured motorneurons from the snail, 
Lymnaea stagnalis, that the RXR and the novel, non-chordate RAR, play a role in retinoic acid-
induced chemoattraction. In addition, I have shown that both naturally occurring isomers, all-
trans and 9-cis retinoic acid, have a neurotrophic and chemotropic role in vertebrate neurons 
from the frog, Xenopus laevis. Furthermore, I have provided data showing a potential role for the 
RXR and RARβ in RA-mediated growth cone turning of frog embryonic spinal cord neurons. 
Using immunocytochemistry, I have also provided data supporting a non-genomic role for RARβ 
in cultured vertebrate cells whereby immunoreactivity was found in the cytoplasm, neurite and 
growth cones of embryonic spinal cord neurons.  
4.01 RXR mediates 9-cis and all-trans retinoic acid-induced growth cone guidance 
 Previous evidence by Farrar (2009) showed that an RXR pan-antagonist, PA452, was 
unable to block either 9-cis or all-trans RA-induced growth cone turning, which led the author to 
speculate from these findings that RXR may not be involved. However, since then Carter et al. 
(2010) showed that PA452, along with another RXR pan-antagonist, HX531, were able to block 
PA024 (RXR agonist) induced growth cone guidance (with HX531 having more significant 
inhibitory effects than PA452). In contrast, I have shown that the RXR pan-antagonist, HX531, 
was able to block guidance of PeA neuron growth cones to both 9-cis and all-trans RA. 
Accordingly, Carter et al. (2010) indicated that HX531 appeared to have a greater inhibition of 
RXR pan-agonist-induced growth cone turning as it blocked 9 of 10 PA024-induced growth cone 
turns whereas PA452 blocked only 3 of 9 growth cone turns. It is therefore possible that PA452 
does not have as high affinity for the RXR in Lymnaea compared to HX531. Indeed, Takeuchi et 
al. (2010) have suggested previously that PA452 is a selective, but weak RXR antagonist. The 
recently cloned LymRXR has a high homology with vertebrate RXRα (80%) particularly in the 
ligand binding domain, which implies that the application of a RXR antagonist designed against 
the vertebrate RXR, has a high probability of binding and being effective in Lymnaea neurons 
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(Carter et al. 2010). Authors have suggested that HX531 is a more effective antagonist of RXR 
than PA452 (Takeuchi et al. 2010) and has previously been shown to block 9-cis RA-induced 
inhibition of HL-60 (Human promyelocytic leukemia cells) cell proliferation and differentiation 
(Kanayasu-Toyoda et al. 2005). It is also of note that the mean turning angles induced by either 
isomer in the presence of HX531 appears to be more negative than those seen in LE540. It is 
unknown whether this could be due to the higher involvement of the RXR than the RAR in 
growth cone guidance, the differing selectivities of the antagonists, or whether RA is now acting 
as a chemorepellant. In addition it is unknown whether this has any significance to the 
mechanisms involved in growth cone guidance. The all-trans and 9-cis retinoic acid-induced 
growth cone turning angles produced in this thesis were comparable to those previously shown in 
response to these RA isomers in the presence of DMSO with cultured PeA neurons, indicating 
consistency between growth cone assays (Farrar, 2009). Therefore, these data strongly support a 
role for RXR in retinoic acid mediated growth cone turning as being both sufficient and 
necessary for chemoattraction in Lymnaea neurons.   
4.02 LymRXR is present in the growth cones which failed to demonstrate a positive turn 
 Classically, retinoic acid has been known to act through its nuclear receptors, RAR and 
RXR, however, recently our lab has shown non-nuclear localization of RXR in the cytoplasm, 
neurites and growth cones of cultured neurons (Carter et al. 2010). As previously mentioned, 
Carter et al. (2010) demonstrated that 95 of 102 growth cones examined contained RXR, 
however some of the neurites showed little or no RXR staining.  In order to determine if growth 
cones which failed to turn toward an RXR agonist, (either PA024 or retinoic acid) in the 
presence of HX531 was due to a possible absence of the receptor in these particular growth 
cones, I used immunocytochemistry to illustrate RXR immunoreactivity within these neurites. 
As anticipated, it was found that in all cases, regardless of whether the growth cone turned 
toward (i.e. PA024) or away (i.e. all-trans RA in HX531) from the retinoid source, RXR was 
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found to be present in the growth cone. RXR immunoreactivity was also shown for the vertebrate 
RXRα in the cytoplasm, dendrites and axons of vertebrate neurons (Calderon and Kim, 2007). 
Taken together, these data further support a non-genomic role for RXR in RA-mediated growth 
cone turning of Lymnaea neurons. In addition to the findings in our lab, there have been previous 
reports of RXR functioning non-genomically in human platelets (Moraes et al. 2007). More 
specifically, RXR was shown to bind to the G protein, Gq, to inhibit enucleated platelet 
activation.  
Previous work done by Farrar et al. (2009) showed that isolated neurites retained the 
ability to respond to retinoic acid as well as to PA024, indicating that RXR localized in the 
growth cones of these neurons might be mediating this growth cone turning response. It has been 
shown, however, that RA can directly bind to and activate other proteins (other than RXR) and 
thus we cannot entirely rule this out, although evidence supports a role for RXR. For example, 
RA can activate cAMP response element-binding protein (CREB) independent of RAR and RXR 
in human tracheobronchial epithelial cells (Aggarwal et al. 2006). In fact, inhibition of protein 
kinase C (PKC) and extracellular regulated kinase (ERK) blocked RA-mediated activation of 
CREB. In contrast, Farrar et al. (2009) showed that inhibition of PKCα using Gö6976 did not 
significantly block RA-induced chemoattraction suggesting RA-mediated growth cone turning is 
working through a different mechanism. Taken with my previous data, which showed inhibition 
of RA-induced chemoattraction by HX531, these data show, at least in Lymnaea, that RXR is 
indeed mediating the response to RA.  Final confirmation would require binding studies to 
definitively show that the agonist and antagonists are binding to RXR in Lymnaea.   
4.03 All-trans and 9-cis retinoic acid-induced chemoattraction involves the novel, non-
chordate RAR 
Here I have shown, for the first time, a role for the novel, non-chordate RAR in RA-
induced chemoattraction. Recent data from our lab had demonstrated a role for the recently 
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cloned LymRAR in embryonic development and due to its localization in the neurites and growth 
cones of cultured neurons, a role in RA-mediated growth cone guidance was proposed, but not 
investigated (Carter, 2011). Our lab illustrated non-nuclear LymRAR immunoreactivity patterns 
similar to that seen with LymRXR in regenerating neurons. In accordance with my hypothesis 
that the RAR may play a similar role as RXR in RA-induced growth cone guidance, I have 
shown that application of an RAR pan-antagonist, LE540, significantly reduced the turning angle 
towards both all-trans and 9-cis retinoic acid. The idea that RAR plays a role in RA-mediated 
growth cone guidance is not surprising as previous evidence in our lab showed that the LymRAR 
shares 100% amino acid identity at the residues thought to interact with RA in the active binding 
site (Carter, 2011). In addition, the RARβ-selective antagonist, LE135, has been shown to inhibit 
limb and spinal cord regeneration in the newt and cause embryo malformations in Lymnaea 
(Carter et al, 2011; Carter, 2011 Dmetrichuk et al. 2005). Taken together, these data strongly 
support a role for RAR in the developmental and regenerative processes. 
It was previously thought that Lymnaea did not possess RARs, however questions arose 
about its presence since its proposed natural ligand, all-trans RA, was identified in the Lymnaea 
CNS (Dmetrichuk et al. 2008). Because both RA isomers are known to bind RAR in vertebrates, 
it is not unexpected that LE540 was able to block all-trans and 9-cis RA-induced growth cone 
turning. Prior work with the RAR antagonists, LE540 and LE135, had not shown any direct 
evidence of an interaction between all-trans RA and RAR (Carter et al. 2011). However, recent 
work by Campo-Paysaa et al. (2008) predicted the binding of all-trans RA to the RAR from the 
mollusc Lottia gigantea based on ligand binding domain conservation. These recent data, along 
with my present results, provide evidence for all-trans RA acting through RAR in the mollusc 
and supports a novel role for RAR in growth cone guidance in cultured invertebrate 
motorneurons.  
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4.04 Growth cone guidance through RXR is retained in the presence of an RAR antagonist 
Recently, Carter et al. (2010) showed that when PA024 was focally applied to 
regenerating growth cones in the presence of PA452 or HX531, both antagonists blocked RXR 
agonist-induced growth cone turning. This evidence suggests that the agonist is likely relatively 
selective for LymRXR and may have little cross-reactivity with RAR, however, this does not 
show selectivity of the RXR antagonists. Furthermore, we were unsure if the RAR pan-
antagonist, LE540, cross-reacts with RXR and that the LE540 inhibition of RA-induced 
chemoattraction was in part due to that. As stated previously, LE540 has been shown to be much 
less selective for the vertebrate RARs than LE135. Binding assays revealed binding of LE540, 
albeit with low affinity, to the vertebrate RXR subtypes, yielding a 3-7 fold lower affinity than 
for RAR subtypes (Umemiya, 1997).  
Interestingly, I showed that PA024 is able to retain its ablilty to attract Lymnaea growth 
cones even in the presence of LE540 (Figure 16; p>0.05), suggesting there is little cross-
reactivity of LE540 with LymRXR. These data support previous literature that showed that the 
combination of an RXR agonist (SR11234) with an RAR antagonist (Ro41-5253) is still able to 
induce differentiation and apotosis of promyelocytic cells (Botling et al. 1997). Moreover, 
activation of RXR has been shown to induce differentiation of stem cells to a muscle lineage, 
independent of RAR activity (Le May et al. 2011). Activation of RXR independent of RAR is 
best illustrated by my results showing that PA024 is able to induce growth cone turning despite 
the presence of LE540, presumably blocking RAR activity. Although these data provide 
evidence that RXR may act independently of RAR to mediate chemotaxis to the RXR agonist, it 
remains unclear whether this is the case in response to retinoic acid.  
It is possible that in the case of RA-induced growth cone guidance, RA binds both RAR 
and RXR and induces heterodimerization to elicit chemoattraction, so neither receptor can act 
alone. On the other hand, it is possible that RA first activates RAR which heterodimerizes with 
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RXR to elicit its effects and therefore, antagonizing either of the receptors renders RA inactive. 
Heterodimerization of RAR/RXR has mainly been shown in vertebrates, however there is one 
example in the invertebrate chordate, Polyandrocarpa misakiensis (budding ascidian), where 
RAR and RXR heterodimerize and act as transcriptional activators in the presence of RA 
(Kamimura et al. 2000). In the case of the synthetic RXR ligand, binding only to RXR may 
allow it to operate as a homodimer independent of RAR or as a heterodimer with potential 
orphan receptors to elicit growth cone turning. The RXR is known to heterodimrize with several 
orphan receptors including peroxisome proliferator-activated receptor (PPAR), nerve growth 
factor- induced clone B (NGFIB)  and the nuclear receptor related 1 (Nurr-1) which is located in 
dopaminergic neurons (Mangelsdorf and Evans, 1995). It has previously been suggested that 
RXR-selective agonists alone cannot induced RAR/RXR heterodimerization and therefore RA-
mediated events (Gronemeyer et al. 2004), but it is unclear if this would hold true in 
invertebrates.  Because this is merely speculation, further experiments are required to determine 
the true course of action with which RA stimulates chemotaxis. 
Although the mechanism by which RA elicits its effects remains unclear, evidence 
provided here shows that effects of two different RA isomers were blocked by HX531 and 
LE540. There is growing controversy regarding the binding affinities for each isomer to RAR 
and RXR, however evidence that the RAR pan-antagonist, LE540, is able to block both all-trans  
and 9-cis RA-induced chemoattraction, further supports the idea presented in vertebrates that 
both isomers bind RAR equally (Maden, 2007). Furthermore, data illustrated here showed that 
the RXR pan-antagonist, HX531, blocked both all-trans and 9-cis RA-induced growth cone 
guidance suggesting these two different isomers both bind RXR in Lymnaea. This supports 
previous literature that both isomers bind RXR equally in the locust (Nowickyj et al. 2008). 
Furthermore, experiments in Drosophila and mouse showed that all-trans RA appeared to have 
lower affinity for RXR compared to 9-cis RA, but when you consider that all-trans RA is 
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thought to be present at much higher concentrations than 9-cis RA, its binding to RXR may have 
physiological relevance (Heyman et al. 1992; Ulven et al. 2001). Moreover, the evidence in this 
study that both antagonists are able to block both isomers suggests these two different isomers 
may be working through the same pathway to elicit their effects. 
 
4.05 Activation of the LymRAR may not be sufficient to induce growth cone turning 
Because the RAR pan-antagonist, LE540, showed nearly complete inhibition of RA-
induced growth cone turning, I assessed whether the RAR pan-agonist, TTNPB, could induce 
growth cone turning similar to that seen with not only RA, but also the RXR pan-agonist PA024. 
When compared to the focal application of DMSO, TTNPB was unable to induce a growth cone 
turning that was significantly larger than that produced by the vehicle control. This result may 
suggest that TTNPB does not bind as efficiently with the LymRAR as it has been shown to in 
vertebrates or that activation of the RAR alone is not sufficient to elicit growth cone guidance. 
Interestingly, bathing L. stagnalis embryos in the RAR pan-agonist, TTNPB, did not show 
malformations at 10
-6
M like those seen with either RA or RAR antagonists (Carter, 2011). 
However, increasing this concentration to 10
-5
M caused complete lysis of the embryos, similar to 
that seen in higher concentrations of the antagonists. Furthermore, TTNPB appeared to induce 
cell death of cultured Lymnaea neurons at a concentration of 10
-5
M (Vesprini, 2011). It may be 
that TTNPB has a weaker binding affinity for RAR when compared to the natural ligand (i.e. all-
trans RA), however when it does bind, TTNPB might have more toxic effects. This is consistent 
with previous reports that TTNPB can be more teratogenic than all-trans RA in different 
vertebrate species (Howard et al., 1989; Kistler et al., 1990; Kochhar, 1987; Loeliger et al., 
1980, Pignatello et al. 1999). In addition, similar teratogenic effects induced by RA were seen 
with TTNPB in frog tadpoles (Maden and Corcoran, 1996), indicating TTNPB may be able to 
mimic some of the effects seen with retinoic acid.  
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During the growth cone assays, TTNPB was applied at a concentration of 10
-5
M in the 
pipette, which could theoretically result in approximately 100-times lower concentration near the 
growth cone (i.e. 10
-7
M; Lohof et al. 1992). Previous studies showed that TTNPB was able to 
effectively activate vertebrate RAR at concentrations as low as 10
-8 
M (Pignatello et al. 2002). 
Interestingly, Pignatello et al. (1999) found that TTNPB had a 10-fold lower affinity for RARs 
when compared with all-trans RA. This evidence suggests that perhaps a 10-fold higher 
concentration of TTNPB in the pipette (10
-4
M or 10
-6
M at the growth cone) may elicit similar 
growth cone turning angles seen in response to RA. Therefore, it still remains unclear as to the 
binding affinity of TTNPB for LymRAR and binding assays would be required to determine if 
these results are indicative of RARs insufficiency to induce growth cone turning or TTNPBs 
inability to bind LymRAR.  
 
4.06 Retinoic acid’s neurotrophic and chemotropic role in Xenopus neurons involves RXR 
and RARβ  
Previous studies have shown a role for several neurotrophic agents in the frog, Xenopus 
laevis including BDNF, NGF and NT-3 (Zheng et al. 1994; Song et al. 1997, Ming et al. 1997, 
2001; Song and Poo, 1998). As previously stated, several of these molecules have been shown to 
direct growth cones of cultured embryonic spinal cord neurons acting as chemoattractive or 
chemorepulsive agents. Because the role of RA as a chemotropic molecule in an invertebrate has 
been well documented, I aimed to determine if there is conservation of this role in individual 
cultured Xenopus laevis embryonic spinal cord neurons, as this had yet to be investigated. 
However, like many investigations before, I first looked at the potential neurotrophic role that 
RA may play in the frog, as this had not been shown in this species.   
For the first time, I showed that both naturally occurring isomers all-trans RA and 9-cis 
RA promoted neurite outgrowth from cultured Xenopus embryonic spinal cord neurons when 
compared to cells cultured in the presence of ethanol. In accordance, previous investigations by 
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Maden et al. (1998a) showed all-trans RA’s ability to induce neurite outgrowth in chick neural 
tube cells. Interestingly, these researchers found that at the same concentration used in our 
experiment (10
-7
M), only neurite length was significantly increased (as opposed to the number of 
neurites), similar to the findings presented here. It has also been shown that all-trans RA in 
combination with the neurotrophic agents NGF or NT-3, enhances survival and neurite 
outgrowth of embryonic chick sympathetic neurons (Plum et al. 2001).  Furthermore, all-trans 
RA was shown to induce significantly more outgrowth of newt spinal cord explants, both in 
number and length (Dmetrichuk et al. 2005). The majority of studies in the literature have 
focused on the effects of all-trans RA on vertebrate regeneration, however there is growing 
evidence of a role for 9-cis RA in limb regeneration (Viviano et al. 1995). In addition, earlier 
work in our lab showed the same neurotrophic effect on newt spinal cord explants with 9-cis RA 
(Rand, 2009; Zeglinski, 2008), coinciding with the effect seen on cultured spinal cord neurons 
from the frog. Based on these data and evidence that endogenous RA is present throughout 
development in Xenopus and many other amphibians (Maden, 1996), it can be said that retinoic 
acid may play a significant role in the regenerative process of the vertebrate CNS and that 9-cis 
retinoic acid may play a larger role than previously thought.  
Although investigators have shown directed outgrowth of newt spinal cord explants 
(Dmetrichuk et al, 2005) and chick neural tube cells to a gradient of all-trans RA (Maden et al. 
1998), growth cone turning assays had not been performed on single vertebrate growth cones to 
conclusively show a chemotropic role for all-trans RA in vertebrate neurons. In addition, little to 
no evidence indicating a chemotropic role for 9-cis RA in vertebrates has been shown. For the 
first time, I showed that endogenous RA isomers, all-trans and 9-cis RA were able to induce 
significantly higher mean growth cone turning angles compared to focal application of ethanol 
alone. This is in accordance with previous studies using all-trans and 9-cis RA soaked beads 
which were shown to guide newly regenerating newt spinal cord explant neurites toward the 
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bead (Dmetrichuk et al. 2005; Rand, 2009, Zeglinski, 2008).  Due to the paucity of studies on 
RA-induced growth cone turning in vertebrate neurons, little is known regarding the receptor(s) 
mediating this response. Thus, I aimed to show the potential role of RAR, specifically the β 
subtype (since previous studies in our lab have implicated this receptor in directed outgrowth 
from spinal cord) (Carter, 2011; Carter et al., 2011; Dmetrichuk et al. 2005), in mediating this 
turning behavior to its proposed natural ligand, all-trans RA. Interestingly, all-trans RA-induced 
growth cone turning was blocked in the presence of the RARβ-selective antagonist, LE135. This 
is not the first time RARβ has been implicated in a regenerative process as RARβ2 was 
suggested as the primary mediator of the RA regenerative signal in the mouse DRG and was 
shown to stimulate neurite regeneration in the mouse spinal cord (Corcoran et al., 2000; 
Corcoran et al. 2002). Dmetrichuk et al. (2005) also showed that LE135 significantly reduced 
neurite outgrowth of newt spinal cord explants elicited by all-trans RA. Furthermore, LE135 was 
shown to inhibit newt tail and caudal spinal cord regeneration (Carter et al., 2011). Moreover, 
RARβ2 expression was found to be up-regulated in the regenerating newt tail and the protein is 
present in the spinal cord during tail regeneration (Carter et al., 2011). Taken together, these data 
strongly support a role for RARβ not only in limb and spinal cord regeneration, but also growth 
cone guidance by mediating the response to all-trans RA. Furthermore, expression of a 
dominant-negative RARβ in Xenopus embryos interfered with retinoid teratogenesis and induced 
specific hindbrain and neural tube abnormalities (van der Wees et al. 1998), suggesting RARβ 
mediates the developmental effects of RA. Given the evidence for a role for RARβ in CNS 
regeneration, especially in vertebrates, I believe it would be interesting to test if an RARβ-
selective agonist (i.e. CD2019; Agudo et al. 2010) would be able to elicit positive growth cone 
turning as this agonist has been shown to overcome inhibition of axonal outgrowth in the rat 
spinal cord (Agudo et al. 2010). Furthermore, TTNPB, an RAR pan-agonist, which was designed 
against the vertebrate RARs, may be able to induce similar growth cone turning behavior seen 
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with RA, even though it failed to do so in the invertebrate preparation. If these agonists were 
able to induce positive growth cone turning, it would suggest that the vertebrate RAR is 
sufficient to mediate the effects of retinoids on growth cone turning. However, testing the effects 
of adding the RXR agonist, HX531, to the bath while applying the RAR agonist would 
determine whether activation of both RA receptors is required for this morphological response, 
or whether the receptors may act independently.  
As we have shown, in addition to the ability of all-trans RA to guide vertebrate growth 
cones, 9-cis RA was able to produce a mean turning angle significantly higher than application 
of ethanol alone. Subsequently, I decided to assess the role that the RXR may play in mediating 
this response, as previous literature suggests that 9-cis RA is the primary ligand for RXR in 
vertebrates, however RAR is thought to be the primary receptor for all-trans RA. Bath 
application of the RXR pan-antagonist, HX531, significantly reduced the mean turning angle 
induced by 9-cis RA suggesting a role for this receptor in this turning behavior in vertebrate 
embryonic neurons. This is the first evidence that RXR may mediate growth cone guidance in a 
vertebrate model system. Although RXR has not been implicated in growth cone guidance, it has 
been implicated in several species as playing a part in neural regeneration and protection. Several 
RXR isoforms were present in the cytoplasm of cultured rat hippocampal neurons (Calderon and 
Kim, 2007) and RXRα was, interestingly, localized in the axonal compartment of regenerating 
rat sciatic nerves (Zhelyaznik and Mey, 2006) and dendrites of rat spinal cord tissue (Schrage et 
al. 2006). Moreover, adult mice with a mutated RXRγ show disruption in neuronal plasticity in 
the hippocampal area, suggesting a possible disruption of growth cone guidance required to form 
new synaptic connections (Chiang, et al. 1998). Furthermore, artificially activating RXR with a 
synthetic ligand promotes survival of rat dopaminergic neurons in vitro (Wallen-Mackenzie et al. 
2003). In Xenopus, by artificially increasing RA levels and more specifically RXRβ, the number 
of primary neurons in the developing embryo significantly increases, showing that this receptor 
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is active in the neural plate and tube, the area from which these neurons were isolated (Maden, 
2007). Based on the evidence presented here, it can be said that RXR plays a role in not only 
neuroprotection, but neuronal regeneration and that it may mediate retinoic acid-induced 
chemoattraction.  It would therefore be interesting to test whether the RXR pan-agonist, PA024, 
would be able to induce positive growth cone turning, similar to that seen in Lymnaea, and 
therefore whether the RXR is capable of acting independent of RAR, as this has not been shown 
in this species. 
4.07 Non-nuclear localization of RARβ in cultured embryonic spinal cord neurons 
Based on tissue immunohistochemistry in the newt tail and spinal cord regenerate, it had 
been suggested that RARβ may act outside the nucleus (Carter, 2011). However, non-nuclear 
staining of a vertebrate RARβ has not been shown in individual vertebrate neurons, although it 
has recently been illustrated in the invertebrate model. Subsequently, I employed 
immunocytochemistry to determine the distribution of RARβ in cultured embryonic Xenopus 
spinal cord neurons. Interestingly, I showed that in all 10 neurons stained for the vertebrate 
RARβ, all showed non-nuclear immunoreactivity, where RARβ was localized in the cytoplasm, 
neurites and growth cones. This is a pattern similar to that seen previously with RAR and RXR 
in Lymnaea motorneurons (Carter, 2011). The antibody used in this experiment was a custom-
made antibody against a synthetic peptide from the hinge region between the DNA-binding 
domain (DBD) and the ligand binding domain (LBD) of the newt, Notopthalmus viridescens, 
RARβ2. The NvRARβ2 shares ~90% amino acid identity with the Xenopus RARβ. In fact, the 
custom made antibody epitope aligns in a highly conserved amino acid sequence between the 
newt and Xenopus RARβ (Figure 25), which indicates that the immunofluorescence observed in 
cultured Xenopus spinal cord neurons can likely be attributed to RARβ . These data show for the 
first time, non-nuclear staining of a vertebrate RARβ in single vertebrate neurons and provides 
strong evidence supporting a non-genomic role for this receptor in neurite outgrowth and RA 
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mediated chemoattraction. This is not the first evidence showing non-nuclear localization of 
RAR in vertebrate cells and tissues as RARα and β were shown to be present in the cytoplasm of 
rat Schwann cells following sciatic nerve injury (Zhelyaznik and Mey, 2006). In addition, 
NvRARβ2 was shown to be localized in ependymal cells surrounding the central canal of the 
spinal cord, the outer perimeter of spinal cord (meninges) and cytoplasm of cells in the wound 
epidermis, all in the regenerating newt tail (Carter et al., 2011). Evidence presented here and 
previously, supports the hypothesis of a non-genomic role for RARβ in spinal cord and limb 
regeneration as well as RA-mediated chemoattraction.  
This would not be the first time a non-genomic role for RAR has been suggested 
however, in fact there are several known examples of vertebrate RARs functioning non-
genomically. Liao et al. (2004) demonstrated that RARβ-selective agonists could elicit 
neurotransmitter release from the Xenopus neuromuscular junction independent of the cell body. 
These data are intriguing since the cells used in my own Xenopus experiments were cultured 
from the neural tube and surrounding embryonic tissue containing a heterogeneous mix of 
neuronal and non-neuronal cells which have been shown to form functional neuromuscular 
junctions in culture (Chow and Poo, 1985). Furthermore, cytoplasmically localized RARs were 
shown to activate both Erk (1/2) and subsequently CREB when bound by retinoic acid in rat 
cerebrocortical and DRG neurons (Canon et al. 2004). Moreover, translational repression of 
dendritically localized GluR1 mRNA by RARα has been demonstrated and this repression was 
lifted when bound by retinoic acid (Poon and Chen, 2008). Although my data suggest, but do not 
definitively show a potential non-genomic role for RARβ in RA-mediated chemoattraction and 
neurite outgrowth, we would need to repeat prior experiments by Farrar et al. (2009) using 
isolated growth cones as well as using local transcriptional inhibitors (i.e. actinomycin D) to 
determine if RARβ is indeed working through a non-genomic mechanism. This technique may 
be more difficult with Xenopus spinal cord cell cultures, as neurite extensions are not as long or 
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robust as those seen in Lymnaea and there is no evidence indicating whether Xenopus neurites 
survive without the cell body or for how long.  
 
Figure 25. Protein sequence alignment. Basic local alignment search tool (BLAST) alignment 
of the newt RARβ-2 sequence against the Xenopus RARβ and the custom made RARβ antibody 
(Ab) epitope. Alignment shows the conserved sequence where the antibody binds each protein 
indicating the fluorescence seen in immunohistochemistry can be attributed to RARβ (National 
Centre for Biological Information; NCBI). 
 
 
 
4.08 What pathway is involved in the growth cone in response to RA application? 
i. Orphan Receptors 
This work, for the first time, shows evidence for the conservation of the neurotrophic and 
chemotropic role of retinoic acid in the frog, Xenopus laevis. In addition, this work demonstrates 
the chemoattractive properties of RA at the level of individual vertebrate growth cones for the 
first time. Although the mechanism involved in this process is still unknown, several possibilities 
exist. As alluded to earlier, based on results from work with the RAR and RXR antagonists, a 
potential main player involved in mediating the response to both isomers of RA may be the 
orphan receptors with which RXR binds, the first of which is Nurr-1. In Nurr-1
-/-
 rats, 
dopaminergic neurons fail to develop. The authors suggested that perhaps activation of RXR and 
therefore Nurr-1 via RA, may promote the development and subsequently the regeneration of 
these cells (Zetterstrom et al., 1997). Although Nurr-1 is present only in vertebrates, there is an 
invertebrate ortholog of the same nuclear receptor subfamily 4 (NR4). This receptor was 
originally identified in Drosophila, NR4A4, also known as Drosophila hormone receptor-like 38 
(DHR38; Wu and LoVerde, 2008). DHR38 is active throughout development in Drosophila, and 
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much like Nurr-1 in vertebrates, acts to induce differentiation of neuronal tissues to a 
dopaminergic fate (Davis et al. 2007). Another potential receptor involved may be PPAR which 
is located in peroxisome membranes throughout the cytoplasm and was first identified in 
Xenopus (Dreyer et al. 1992). The PPAR/RXR heterodimer has been shown to be formed and 
able to induce gene expression in response to 9-cis retinoic acid (Kliewer et al. 1992). 
Furthermore, non-genomic effects of PPARγ have been shown in which activation of this 
receptor in enucleated platelets resulted in inhibition of aggregation and calcium mobilization 
(Moraes et al. 2009). Although PPARs have only been identified in vertebrates, there is evidence 
of a closely related orphan receptor, E75, identified in Drosophila (Schoonjans et al. 1996). 
Taken together, these data elucidate a potential role for Nurr-1 or PPAR in mediating RA-
induced growth cone turning in conjunction with RXR. In order to elucidate the role these 
receptors might be playing, it would be worthwhile to conduct growth cone assays in the 
presence of commercially available Nurr-1 or PPAR antagonists along with the RAR pan-
antagonist, LE540 while focally applying the RXR pan-agonist. This would determine if RXR-
mediated growth cone turning is acting through a homodimer or perhaps through these orphan 
receptors.  
ii. Calcium 
In addition to working through its receptors, RAR and RXR, there is a vast amount of 
literature on RA’s ability to modulate cell responses through different intracellular mechanisms, 
one of which is calcium. Previous evidence has shown that RA exposure can increase 
intracellular calcium levels in human (Gao et al., 1998; Launay et al., 2003) and rat (Short et al. 
1991) cell lines. In addition, RA has been shown to upregulate calcium binding proteins, thus 
altering a cell’s repsonse to calcium signals (Lawson et al. 1999; Chen and Napoli, 2008). 
Furthermore, intracellular calcium levels are known to be highly involved in the promotion of 
neural regeneration following injury and calcium flux plays a crucial role in neurite extension 
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and growth cone behaviour (Henley and Poo, 2004; Ibarretxe et al., 2007; McClellan et al., 
2008; Song and Poo, 1999), a phenomena RA is known to induce. Recent evidence from our lab 
has shown that application of RA to cultured Visceral F neurons from Lymnaea causes a 
significant reduction in intracellular calcium levels. This calcium decrease was, however, shown 
only at high levels of RA, (contrary to previous evidence of the ablilty of RA to increase  
calcium levels), although this work was done in adult neurons (Vesprini, 2011) as opposed to 
immature, differentiating neurons. In relation to growth cone motility and guidance, it has been 
suggested by several groups that local fluctuations in intracellular calcium are directly 
responsible for the attractiveness or repulsiveness of various guidance cues. In fact, calcium 
imaging shows that small elevations in calcium in the growth cone lead to growth cone 
repulsion, whereas medium spikes in local calcium results in attraction of the growth cone 
(Henley and Poo, 2004; Wen et al. 2004). Interestingly, large elevations in local calcium levels 
induce repulsion of growth cones. (Robles et al. 2003). Moreover, evidence by Farrar (2009) 
showed that application of the known calcium channel blocker, cadmium, to Lymnaea neurons, 
caused inhibition of all-trans RA induced growth cone turning, suggesting that influx of calcium 
is important in this response. Finally, Song and Poo (1998) showed that Xenopus spinal cord 
neurons cultured in low calcium saline lost their attractiveness to the chemoattractant guidance 
cues BDNF and NGF. Though this evidence strongly supports a role for calcium in regeneration 
and more specifically, RA-mediated regeneration and chemoattraction, investigations showing 
RA’s direct effect on calcium levels at the growth cone level have yet to be performed.       
iii. cAMP and PKA 
 Substantial work has indicated the interaction between RA signaling and other 
intracellular signaling cascades, most notably the cAMP pathway, which is regulated by the 
enzyme, protein kinase A (PKA). RA has been shown to activate the cAMP response element-
binding protein (CREB) independent of its receptors, RAR and RXR (Aggarwal et al. 2006). 
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This mechanism is unlikely in our case as work with RAR and RXR antagonists would not have 
been successful in blocking RA-mediated growth cone turning. However, direct interactions 
between RA and PKA have been well documented, for example, PKA inhibition negates RA-
induced cell survival (Kholodenko et al., 2007) and RARβ-2-induced neurite outgrowth (Wong 
et al. 2006). Moreover, RA-induced increases in RAR mediated transcriptional activity have 
been shown to be inhibited in the presence of a PKA  antagonist (Saito et al. 2010).  Not only 
does PKA appear to mediate RA’s neurotrophic effects, it has been shown to mediate growth 
cone turning in response to other tropic factors. More specifically, inhibition of PKA in cultured 
Xenopus embryonic spinal cord neurons caused previously attractive guidance cues to become 
repellant, much like experiments done in low calcium. Interestingly, activation of PKA caused 
previously repellant guidance cues to become attractive (Song and Poo, 1998). This evidence 
shows that high levels of cAMP result in chemoattraction and conversely, low levels lead to 
chemorepulsion. Therefore, it is entirely possible that RA regulates cAMP levels through PKA. 
It may act as an agonist either directly or indirectly through the RAR or RXR to raise levels 
within the growth cone resulting in an attractive response by the growth cone. Although, direct 
evidence for the role of PKA in RA-mediated growth cone turning has not yet been shown, it 
would be intriguing to test if PKA inhibition resulted in RA becoming a chemorepellant. 
Evidence in our lab has shown that PKA inhibition did not alter RA-induced electrophysiological 
effects (Vesprini, 2011), but these may require completely different mechanisms than those 
utilized in a morphological response. 
4.09 RA as a therapeutic agent? 
 As is evident in the literature, RA has a quite complex and extensive role in several 
processes from development to regeneration, however the fundamental pathway(s) through 
which RA elicits its effects must first be characterized before therapeutic use can be considered. 
However, it appears to have great potential for use in neurodegenerative disease. It has been 
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shown extensively in invertebrates and vertebrates that RA has the capacity to induce significant 
neural regeneration in vitro (Dmetrichuk et al. 2005; Dmetrichuk et al. 2006) as well as guide 
axonal processes (Dmetrichuk et al. 2006; Dmetrichuk et al. 2008; Farrar et al. 2009; Carter et 
al. 2010). Furthermore, functional recovery has been shown in rat and mouse models of spinal 
cord injury and Parkinson’s disease whereby pharmacological application of RA or up-regulation 
of its receptors induced regeneration of neural tissues (Agudo et al. 2010; Ulusoy et al. 2011; 
Wong et al. 2006; Yip et al. 2006). Moreover, faulty RA signaling  has been implicated in a 
number of neurodegenerative diseases, most notably Parkinson’s disease (Krezel et al. 1998) and 
motorneuron disease (i.e. amyotrophic lateral sclerosis (ALS); Corcoran et al. 2002b). In 
addition, RA has been thought to play a role in affective disorders like depression (Bremner and 
McCaffery, 2008) and schizophrenia (Krezel et al. 1998). Although evidence supporting the use 
of RA as a therapeutic agent is growing, potential side effects and interactions with other 
pathways have yet to be identified before RA’s potential benefits can be applied.   
4.10 RXR and RAR antagonist selectivity 
 The majority of the work presented here relied upon the presumed selectivity of synthetic 
antagonists of the retinoid receptors, RXR and RAR. Since these molecules were designed 
against vertebrate receptors, it is unknown how selective they are for the Lymnaea receptors and 
therefore any data presented can only suggest, but not definitively show, a role for either of the 
retinoid receptors. However,  LymRXR has a relatively high overall homology to rat and human 
RXR (~80%) and 100% amino acid identity at the specific residues thought to interact with RA 
(Carter et al. 2010). Therefore, data showing uninhibited growth cone turning in response to the 
RXR pan-agonist, PA024, in the presence of the RAR pan-antagonist, LE540, suggest relatively 
high selectivity for the RXR. However, growth cone assays performed using embryonic spinal 
cord neurons from Xenopus can be more easily relied upon. The reason for this is due to the high 
homology between Xenopus RARβ and RXR compared to other vertebrates like the rat and 
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human where the amino acid identity is ~90% between these receptors. As stated previously, 
binding assays for these synthetic agonists and antagonists are required in order to conclusively 
show the role of the retinoid receptors in RA-induced growth cone turning. 
 4.11 Summary 
 In this study, I have shown that RA-induced chemoattraction of Lymnaea stagnalis PeA 
motorneuron growth cones is mediated by both the RXR and RAR. In addition, RXR-mediated 
growth cone turning, at least in response to activation by the synthetic agonist, appears to act 
independently of the RAR, potentially through parallel pathways which have yet to be identified. 
For the first time I showed that RA’s neurotrophic and chemotropic role in invertebrates is 
conserved in frog embryonic spinal cord neurons, where both isomers of RA, all-trans and 9-cis, 
induced significant neurite outgrowth as well as positive growth cone turning. Furthermore, all-
trans RA-induced chemoattraction may be mediated by RARβ, whereas 9-cis RA-induced 
growth cone guidance may act through RXR.  Interestingly, RARβ was localized in a non-
nuclear distribution in cultured embryonic spinal cord neurons, potentially indicating a novel, 
non-genomic role for RARβ in vertebrate neurite outgrowth and chemoattraction. These results 
provide further evidence supporting a conservation of the retinoid signaling pathway in 
vertebrate neurons and indicate that the same receptors may be mediating the chemoattractive 
response induced by RA. 
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Chapter 5:  
Appendix 1 
 
 
Figure 26. Two isomers of retinoic acid. A. all-trans retinoic acid. B. 9-cis retinoic acid. 
 
 
 
 
Figure 27. Structure of the synthetic RXR ligands. A. RXR pan-antagonist HX531. B. RXR 
pan-agonist PA024. 
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Figure 28. Structure of the synthetic RAR ligands. A. RAR pan-antagonist LE540. B. RARβ-
2 selective antagonist LE135. C. RAR pan-agonist TTNPB.    
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